context
stringlengths 21
33.9k
| category
stringclasses 2
values | entity
stringlengths 1
12
| entity_type
stringclasses 5
values | query
stringlengths 97
3.31k
| answer
stringlengths 12
169
|
|---|---|---|---|---|---|
Citizens sponsors a 401(k) Plan under which employee contributions are matched by the Company dollar for dollar up to 4 % after the employee completes of one year of service. In addition, substantially all employees will receive an additional 1.5 % of their eligible earnings after completion of one year of service, subject to limits set by the Internal Revenue Service. Amounts expensed by the Company were $ 78 million in 2023 compared to $ 86 million in 2022 and $ 63 million in 2021.
|
text
|
86
|
monetaryItemType
|
text: <entity> 86 </entity> <entity type> monetaryItemType </entity type> <context> Citizens sponsors a 401(k) Plan under which employee contributions are matched by the Company dollar for dollar up to 4 % after the employee completes of one year of service. In addition, substantially all employees will receive an additional 1.5 % of their eligible earnings after completion of one year of service, subject to limits set by the Internal Revenue Service. Amounts expensed by the Company were $ 78 million in 2023 compared to $ 86 million in 2022 and $ 63 million in 2021. </context>
|
us-gaap:DefinedContributionPlanCostRecognized
|
Citizens sponsors a 401(k) Plan under which employee contributions are matched by the Company dollar for dollar up to 4 % after the employee completes of one year of service. In addition, substantially all employees will receive an additional 1.5 % of their eligible earnings after completion of one year of service, subject to limits set by the Internal Revenue Service. Amounts expensed by the Company were $ 78 million in 2023 compared to $ 86 million in 2022 and $ 63 million in 2021.
|
text
|
63
|
monetaryItemType
|
text: <entity> 63 </entity> <entity type> monetaryItemType </entity type> <context> Citizens sponsors a 401(k) Plan under which employee contributions are matched by the Company dollar for dollar up to 4 % after the employee completes of one year of service. In addition, substantially all employees will receive an additional 1.5 % of their eligible earnings after completion of one year of service, subject to limits set by the Internal Revenue Service. Amounts expensed by the Company were $ 78 million in 2023 compared to $ 86 million in 2022 and $ 63 million in 2021. </context>
|
us-gaap:DefinedContributionPlanCostRecognized
|
Redeemable at the Company’s option, in whole or in part, on any dividend payment date on or after the date stated, or in whole but not in part, at any time within 90 days following a regulatory capital treatment event as defined in the applicable certificate of designations, in each case at a redemption price equal to $ 1,000 per share plus any declared and unpaid dividends, without accumulation of any undeclared dividends. Under current rules, any redemption is subject to approval by the FRB.
|
text
|
1000
|
perShareItemType
|
text: <entity> 1000 </entity> <entity type> perShareItemType </entity type> <context> Redeemable at the Company’s option, in whole or in part, on any dividend payment date on or after the date stated, or in whole but not in part, at any time within 90 days following a regulatory capital treatment event as defined in the applicable certificate of designations, in each case at a redemption price equal to $ 1,000 per share plus any declared and unpaid dividends, without accumulation of any undeclared dividends. Under current rules, any redemption is subject to approval by the FRB. </context>
|
us-gaap:PreferredStockRedemptionPricePerShare
|
During the years ended December 31, 2023 and 2022, the Company repurchased $ 906 million, or 28,473,805 shares, and repurchased $ 153 million, or 3,815,922 shares, respectively, of its outstanding common stock, which are held in treasury stock.
|
text
|
906
|
monetaryItemType
|
text: <entity> 906 </entity> <entity type> monetaryItemType </entity type> <context> During the years ended December 31, 2023 and 2022, the Company repurchased $ 906 million, or 28,473,805 shares, and repurchased $ 153 million, or 3,815,922 shares, respectively, of its outstanding common stock, which are held in treasury stock. </context>
|
us-gaap:TreasuryStockValueAcquiredCostMethod
|
During the years ended December 31, 2023 and 2022, the Company repurchased $ 906 million, or 28,473,805 shares, and repurchased $ 153 million, or 3,815,922 shares, respectively, of its outstanding common stock, which are held in treasury stock.
|
text
|
28473805
|
sharesItemType
|
text: <entity> 28473805 </entity> <entity type> sharesItemType </entity type> <context> During the years ended December 31, 2023 and 2022, the Company repurchased $ 906 million, or 28,473,805 shares, and repurchased $ 153 million, or 3,815,922 shares, respectively, of its outstanding common stock, which are held in treasury stock. </context>
|
us-gaap:TreasuryStockSharesAcquired
|
During the years ended December 31, 2023 and 2022, the Company repurchased $ 906 million, or 28,473,805 shares, and repurchased $ 153 million, or 3,815,922 shares, respectively, of its outstanding common stock, which are held in treasury stock.
|
text
|
153
|
monetaryItemType
|
text: <entity> 153 </entity> <entity type> monetaryItemType </entity type> <context> During the years ended December 31, 2023 and 2022, the Company repurchased $ 906 million, or 28,473,805 shares, and repurchased $ 153 million, or 3,815,922 shares, respectively, of its outstanding common stock, which are held in treasury stock. </context>
|
us-gaap:PaymentsForRepurchaseOfCommonStock
|
During the years ended December 31, 2023 and 2022, the Company repurchased $ 906 million, or 28,473,805 shares, and repurchased $ 153 million, or 3,815,922 shares, respectively, of its outstanding common stock, which are held in treasury stock.
|
text
|
3815922
|
sharesItemType
|
text: <entity> 3815922 </entity> <entity type> sharesItemType </entity type> <context> During the years ended December 31, 2023 and 2022, the Company repurchased $ 906 million, or 28,473,805 shares, and repurchased $ 153 million, or 3,815,922 shares, respectively, of its outstanding common stock, which are held in treasury stock. </context>
|
us-gaap:TreasuryStockSharesAcquired
|
This plan provides eligible employees an opportunity to purchase CFG common stock at a 10 % discount. Participants may contribute up to 10 % of eligible compensation to the ESPP and may purchase up to $ 25,000 worth of stock in any calendar year. Offering periods under the ESPP are quarterly, with shares of CFG common stock purchased on the last day of each quarter at a 10 % discount from the fair market value, defined as the closing price on the day of purchase. Prior to the date the shares are purchased, participants have no rights or privileges as a stockholder with respect to shares purchased at the end of the offering period.
|
text
|
10
|
percentItemType
|
text: <entity> 10 </entity> <entity type> percentItemType </entity type> <context> This plan provides eligible employees an opportunity to purchase CFG common stock at a 10 % discount. Participants may contribute up to 10 % of eligible compensation to the ESPP and may purchase up to $ 25,000 worth of stock in any calendar year. Offering periods under the ESPP are quarterly, with shares of CFG common stock purchased on the last day of each quarter at a 10 % discount from the fair market value, defined as the closing price on the day of purchase. Prior to the date the shares are purchased, participants have no rights or privileges as a stockholder with respect to shares purchased at the end of the offering period. </context>
|
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardDiscountFromMarketPricePurchaseDate
|
This plan provides eligible employees an opportunity to purchase CFG common stock at a 10 % discount. Participants may contribute up to 10 % of eligible compensation to the ESPP and may purchase up to $ 25,000 worth of stock in any calendar year. Offering periods under the ESPP are quarterly, with shares of CFG common stock purchased on the last day of each quarter at a 10 % discount from the fair market value, defined as the closing price on the day of purchase. Prior to the date the shares are purchased, participants have no rights or privileges as a stockholder with respect to shares purchased at the end of the offering period.
|
text
|
10
|
percentItemType
|
text: <entity> 10 </entity> <entity type> percentItemType </entity type> <context> This plan provides eligible employees an opportunity to purchase CFG common stock at a 10 % discount. Participants may contribute up to 10 % of eligible compensation to the ESPP and may purchase up to $ 25,000 worth of stock in any calendar year. Offering periods under the ESPP are quarterly, with shares of CFG common stock purchased on the last day of each quarter at a 10 % discount from the fair market value, defined as the closing price on the day of purchase. Prior to the date the shares are purchased, participants have no rights or privileges as a stockholder with respect to shares purchased at the end of the offering period. </context>
|
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionRate
|
There are 40,750,357 shares of common stock available for awards to be granted under the Omnibus Plan and Directors Plan. In addition, there are 2,991,009 shares available for issuance under the ESPP.
|
text
|
40750357
|
sharesItemType
|
text: <entity> 40750357 </entity> <entity type> sharesItemType </entity type> <context> There are 40,750,357 shares of common stock available for awards to be granted under the Omnibus Plan and Directors Plan. In addition, there are 2,991,009 shares available for issuance under the ESPP. </context>
|
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant
|
There are 40,750,357 shares of common stock available for awards to be granted under the Omnibus Plan and Directors Plan. In addition, there are 2,991,009 shares available for issuance under the ESPP.
|
text
|
2991009
|
sharesItemType
|
text: <entity> 2991009 </entity> <entity type> sharesItemType </entity type> <context> There are 40,750,357 shares of common stock available for awards to be granted under the Omnibus Plan and Directors Plan. In addition, there are 2,991,009 shares available for issuance under the ESPP. </context>
|
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant
|
Share-based compensation expense was $ 87 million, $ 84 million
|
text
|
87
|
monetaryItemType
|
text: <entity> 87 </entity> <entity type> monetaryItemType </entity type> <context> Share-based compensation expense was $ 87 million, $ 84 million </context>
|
us-gaap:AllocatedShareBasedCompensationExpenseNetOfTax
|
Share-based compensation expense was $ 87 million, $ 84 million
|
text
|
84
|
monetaryItemType
|
text: <entity> 84 </entity> <entity type> monetaryItemType </entity type> <context> Share-based compensation expense was $ 87 million, $ 84 million </context>
|
us-gaap:AllocatedShareBasedCompensationExpenseNetOfTax
|
and $ 59 million for the years ended December 31, 2023, 2022 and 2021, respectively. At December 31, 2023, the total unrecognized compensation expense for unvested awards granted was $ 76 million. This expense is expected to be recognized over a weighted-average period of approximately two years .
|
text
|
59
|
monetaryItemType
|
text: <entity> 59 </entity> <entity type> monetaryItemType </entity type> <context> and $ 59 million for the years ended December 31, 2023, 2022 and 2021, respectively. At December 31, 2023, the total unrecognized compensation expense for unvested awards granted was $ 76 million. This expense is expected to be recognized over a weighted-average period of approximately two years . </context>
|
us-gaap:AllocatedShareBasedCompensationExpenseNetOfTax
|
and $ 59 million for the years ended December 31, 2023, 2022 and 2021, respectively. At December 31, 2023, the total unrecognized compensation expense for unvested awards granted was $ 76 million. This expense is expected to be recognized over a weighted-average period of approximately two years .
|
text
|
76
|
monetaryItemType
|
text: <entity> 76 </entity> <entity type> monetaryItemType </entity type> <context> and $ 59 million for the years ended December 31, 2023, 2022 and 2021, respectively. At December 31, 2023, the total unrecognized compensation expense for unvested awards granted was $ 76 million. This expense is expected to be recognized over a weighted-average period of approximately two years . </context>
|
us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions
|
Citizens recognized income tax benefits related to share-based compensation arrangements of $ 16 million, $ 19 million and $ 12 million for the years ended December 31, 2023, 2022 and 2021, respectively.
|
text
|
16
|
monetaryItemType
|
text: <entity> 16 </entity> <entity type> monetaryItemType </entity type> <context> Citizens recognized income tax benefits related to share-based compensation arrangements of $ 16 million, $ 19 million and $ 12 million for the years ended December 31, 2023, 2022 and 2021, respectively. </context>
|
us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense
|
Citizens recognized income tax benefits related to share-based compensation arrangements of $ 16 million, $ 19 million and $ 12 million for the years ended December 31, 2023, 2022 and 2021, respectively.
|
text
|
19
|
monetaryItemType
|
text: <entity> 19 </entity> <entity type> monetaryItemType </entity type> <context> Citizens recognized income tax benefits related to share-based compensation arrangements of $ 16 million, $ 19 million and $ 12 million for the years ended December 31, 2023, 2022 and 2021, respectively. </context>
|
us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense
|
Citizens recognized income tax benefits related to share-based compensation arrangements of $ 16 million, $ 19 million and $ 12 million for the years ended December 31, 2023, 2022 and 2021, respectively.
|
text
|
12
|
monetaryItemType
|
text: <entity> 12 </entity> <entity type> monetaryItemType </entity type> <context> Citizens recognized income tax benefits related to share-based compensation arrangements of $ 16 million, $ 19 million and $ 12 million for the years ended December 31, 2023, 2022 and 2021, respectively. </context>
|
us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense
|
Excludes investments of $ 58 million included in other assets in the Consolidated Balance Sheets that are measured at fair value using the net asset value per share (or its equivalent) practical expedient. These investments include capital contributions to private investment funds and have unfunded capital commitments of $ 28 million at December 31, 2023, which may be called at any time during prescribed time periods. The credit exposure is generally limited to the carrying amount of investments made and unfunded capital commitments.
|
text
|
58
|
monetaryItemType
|
text: <entity> 58 </entity> <entity type> monetaryItemType </entity type> <context> Excludes investments of $ 58 million included in other assets in the Consolidated Balance Sheets that are measured at fair value using the net asset value per share (or its equivalent) practical expedient. These investments include capital contributions to private investment funds and have unfunded capital commitments of $ 28 million at December 31, 2023, which may be called at any time during prescribed time periods. The credit exposure is generally limited to the carrying amount of investments made and unfunded capital commitments. </context>
|
us-gaap:EquitySecuritiesFvNi
|
Excludes investments of $ 58 million included in other assets in the Consolidated Balance Sheets that are measured at fair value using the net asset value per share (or its equivalent) practical expedient. These investments include capital contributions to private investment funds and have unfunded capital commitments of $ 28 million at December 31, 2023, which may be called at any time during prescribed time periods. The credit exposure is generally limited to the carrying amount of investments made and unfunded capital commitments.
|
text
|
28
|
monetaryItemType
|
text: <entity> 28 </entity> <entity type> monetaryItemType </entity type> <context> Excludes investments of $ 58 million included in other assets in the Consolidated Balance Sheets that are measured at fair value using the net asset value per share (or its equivalent) practical expedient. These investments include capital contributions to private investment funds and have unfunded capital commitments of $ 28 million at December 31, 2023, which may be called at any time during prescribed time periods. The credit exposure is generally limited to the carrying amount of investments made and unfunded capital commitments. </context>
|
us-gaap:FairValueDisclosureOffbalanceSheetRisksAmountLiability
|
Excludes investments of $ 43 million included in other assets in the Consolidated Balance Sheets that are measured at fair value using the net asset value per share (or its equivalent) practical expedient. These investments include capital contributions to private investment funds and have unfunded capital commitments of $ 42 million at December 31, 2022, which may be called at any time during prescribed time periods. The credit exposure is generally limited to the carrying amount of investments made and unfunded capital commitments.
|
text
|
43
|
monetaryItemType
|
text: <entity> 43 </entity> <entity type> monetaryItemType </entity type> <context> Excludes investments of $ 43 million included in other assets in the Consolidated Balance Sheets that are measured at fair value using the net asset value per share (or its equivalent) practical expedient. These investments include capital contributions to private investment funds and have unfunded capital commitments of $ 42 million at December 31, 2022, which may be called at any time during prescribed time periods. The credit exposure is generally limited to the carrying amount of investments made and unfunded capital commitments. </context>
|
us-gaap:EquitySecuritiesFvNi
|
Excludes investments of $ 43 million included in other assets in the Consolidated Balance Sheets that are measured at fair value using the net asset value per share (or its equivalent) practical expedient. These investments include capital contributions to private investment funds and have unfunded capital commitments of $ 42 million at December 31, 2022, which may be called at any time during prescribed time periods. The credit exposure is generally limited to the carrying amount of investments made and unfunded capital commitments.
|
text
|
42
|
monetaryItemType
|
text: <entity> 42 </entity> <entity type> monetaryItemType </entity type> <context> Excludes investments of $ 43 million included in other assets in the Consolidated Balance Sheets that are measured at fair value using the net asset value per share (or its equivalent) practical expedient. These investments include capital contributions to private investment funds and have unfunded capital commitments of $ 42 million at December 31, 2022, which may be called at any time during prescribed time periods. The credit exposure is generally limited to the carrying amount of investments made and unfunded capital commitments. </context>
|
us-gaap:FairValueDisclosureOffbalanceSheetRisksAmountLiability
|
Includes bank-owned life insurance income of $ 93 million, $ 88 million and $ 67 million for the years ended December 31, 2023, 2022 and 2021, respectively.
|
text
|
93
|
monetaryItemType
|
text: <entity> 93 </entity> <entity type> monetaryItemType </entity type> <context> Includes bank-owned life insurance income of $ 93 million, $ 88 million and $ 67 million for the years ended December 31, 2023, 2022 and 2021, respectively. </context>
|
us-gaap:BankOwnedLifeInsuranceIncome
|
Includes bank-owned life insurance income of $ 93 million, $ 88 million and $ 67 million for the years ended December 31, 2023, 2022 and 2021, respectively.
|
text
|
88
|
monetaryItemType
|
text: <entity> 88 </entity> <entity type> monetaryItemType </entity type> <context> Includes bank-owned life insurance income of $ 93 million, $ 88 million and $ 67 million for the years ended December 31, 2023, 2022 and 2021, respectively. </context>
|
us-gaap:BankOwnedLifeInsuranceIncome
|
Includes bank-owned life insurance income of $ 93 million, $ 88 million and $ 67 million for the years ended December 31, 2023, 2022 and 2021, respectively.
|
text
|
67
|
monetaryItemType
|
text: <entity> 67 </entity> <entity type> monetaryItemType </entity type> <context> Includes bank-owned life insurance income of $ 93 million, $ 88 million and $ 67 million for the years ended December 31, 2023, 2022 and 2021, respectively. </context>
|
us-gaap:BankOwnedLifeInsuranceIncome
|
Trust and investment services fees include fees from investment management and brokerage services. Fees from investment management services are based on asset market values and are recognized over the period in which the related service is provided. Brokerage services include custody fees, commission income, trailing commissions and other investment services. Custody fees are recognized on a monthly basis and commission income is recognized on trade date. Trailing commissions, such as 12b-1 fees, insurance renewal income, and income based on asset or investment levels in future periods are recognized when the asset balance is known, or the renewal occurs and the income is no longer constrained. For the years ended December 31, 2023, 2022 and 2021, the Company recognized trailing commissions of $ 15 million, $ 15 million and $ 16 million, respectively, related to ongoing commissions from previous investment sales. Fees from other investment services are recognized upon completion of the service.
|
text
|
15
|
monetaryItemType
|
text: <entity> 15 </entity> <entity type> monetaryItemType </entity type> <context> Trust and investment services fees include fees from investment management and brokerage services. Fees from investment management services are based on asset market values and are recognized over the period in which the related service is provided. Brokerage services include custody fees, commission income, trailing commissions and other investment services. Custody fees are recognized on a monthly basis and commission income is recognized on trade date. Trailing commissions, such as 12b-1 fees, insurance renewal income, and income based on asset or investment levels in future periods are recognized when the asset balance is known, or the renewal occurs and the income is no longer constrained. For the years ended December 31, 2023, 2022 and 2021, the Company recognized trailing commissions of $ 15 million, $ 15 million and $ 16 million, respectively, related to ongoing commissions from previous investment sales. Fees from other investment services are recognized upon completion of the service. </context>
|
us-gaap:ContractWithCustomerLiabilityChangeInTimeframePerformanceObligationSatisfiedRevenueRecognized
|
Trust and investment services fees include fees from investment management and brokerage services. Fees from investment management services are based on asset market values and are recognized over the period in which the related service is provided. Brokerage services include custody fees, commission income, trailing commissions and other investment services. Custody fees are recognized on a monthly basis and commission income is recognized on trade date. Trailing commissions, such as 12b-1 fees, insurance renewal income, and income based on asset or investment levels in future periods are recognized when the asset balance is known, or the renewal occurs and the income is no longer constrained. For the years ended December 31, 2023, 2022 and 2021, the Company recognized trailing commissions of $ 15 million, $ 15 million and $ 16 million, respectively, related to ongoing commissions from previous investment sales. Fees from other investment services are recognized upon completion of the service.
|
text
|
16
|
monetaryItemType
|
text: <entity> 16 </entity> <entity type> monetaryItemType </entity type> <context> Trust and investment services fees include fees from investment management and brokerage services. Fees from investment management services are based on asset market values and are recognized over the period in which the related service is provided. Brokerage services include custody fees, commission income, trailing commissions and other investment services. Custody fees are recognized on a monthly basis and commission income is recognized on trade date. Trailing commissions, such as 12b-1 fees, insurance renewal income, and income based on asset or investment levels in future periods are recognized when the asset balance is known, or the renewal occurs and the income is no longer constrained. For the years ended December 31, 2023, 2022 and 2021, the Company recognized trailing commissions of $ 15 million, $ 15 million and $ 16 million, respectively, related to ongoing commissions from previous investment sales. Fees from other investment services are recognized upon completion of the service. </context>
|
us-gaap:ContractWithCustomerLiabilityChangeInTimeframePerformanceObligationSatisfiedRevenueRecognized
|
At December 31, 2023, the Company had federal and state tax net operating loss carryforwards of $ 651 million and capital loss carryforwards of $ 152 million. The majority of the federal and state tax net operating loss carryforwards, if not utilized, will expire in varying amounts through 2042, while the capital loss and tax credit carryforwards expire in varying amounts through 2027 and 2030, respectively. Limitations on the ability to realize these carryforwards are reflected in the associated valuation allowance. At December 31, 2023, the Company had a valuation allowance of $ 137 million against various deferred tax assets related to federal and state net operating losses, capital losses and state tax credits, as the Company’s current assessment is that it is more likely than not that a portion of the deferred tax assets related to these items will not be realized.
|
text
|
651
|
monetaryItemType
|
text: <entity> 651 </entity> <entity type> monetaryItemType </entity type> <context> At December 31, 2023, the Company had federal and state tax net operating loss carryforwards of $ 651 million and capital loss carryforwards of $ 152 million. The majority of the federal and state tax net operating loss carryforwards, if not utilized, will expire in varying amounts through 2042, while the capital loss and tax credit carryforwards expire in varying amounts through 2027 and 2030, respectively. Limitations on the ability to realize these carryforwards are reflected in the associated valuation allowance. At December 31, 2023, the Company had a valuation allowance of $ 137 million against various deferred tax assets related to federal and state net operating losses, capital losses and state tax credits, as the Company’s current assessment is that it is more likely than not that a portion of the deferred tax assets related to these items will not be realized. </context>
|
us-gaap:OperatingLossCarryforwards
|
At December 31, 2023, the Company had federal and state tax net operating loss carryforwards of $ 651 million and capital loss carryforwards of $ 152 million. The majority of the federal and state tax net operating loss carryforwards, if not utilized, will expire in varying amounts through 2042, while the capital loss and tax credit carryforwards expire in varying amounts through 2027 and 2030, respectively. Limitations on the ability to realize these carryforwards are reflected in the associated valuation allowance. At December 31, 2023, the Company had a valuation allowance of $ 137 million against various deferred tax assets related to federal and state net operating losses, capital losses and state tax credits, as the Company’s current assessment is that it is more likely than not that a portion of the deferred tax assets related to these items will not be realized.
|
text
|
152
|
monetaryItemType
|
text: <entity> 152 </entity> <entity type> monetaryItemType </entity type> <context> At December 31, 2023, the Company had federal and state tax net operating loss carryforwards of $ 651 million and capital loss carryforwards of $ 152 million. The majority of the federal and state tax net operating loss carryforwards, if not utilized, will expire in varying amounts through 2042, while the capital loss and tax credit carryforwards expire in varying amounts through 2027 and 2030, respectively. Limitations on the ability to realize these carryforwards are reflected in the associated valuation allowance. At December 31, 2023, the Company had a valuation allowance of $ 137 million against various deferred tax assets related to federal and state net operating losses, capital losses and state tax credits, as the Company’s current assessment is that it is more likely than not that a portion of the deferred tax assets related to these items will not be realized. </context>
|
us-gaap:TaxCreditCarryforwardAmount
|
At December 31, 2023, the Company had federal and state tax net operating loss carryforwards of $ 651 million and capital loss carryforwards of $ 152 million. The majority of the federal and state tax net operating loss carryforwards, if not utilized, will expire in varying amounts through 2042, while the capital loss and tax credit carryforwards expire in varying amounts through 2027 and 2030, respectively. Limitations on the ability to realize these carryforwards are reflected in the associated valuation allowance. At December 31, 2023, the Company had a valuation allowance of $ 137 million against various deferred tax assets related to federal and state net operating losses, capital losses and state tax credits, as the Company’s current assessment is that it is more likely than not that a portion of the deferred tax assets related to these items will not be realized.
|
text
|
137
|
monetaryItemType
|
text: <entity> 137 </entity> <entity type> monetaryItemType </entity type> <context> At December 31, 2023, the Company had federal and state tax net operating loss carryforwards of $ 651 million and capital loss carryforwards of $ 152 million. The majority of the federal and state tax net operating loss carryforwards, if not utilized, will expire in varying amounts through 2042, while the capital loss and tax credit carryforwards expire in varying amounts through 2027 and 2030, respectively. Limitations on the ability to realize these carryforwards are reflected in the associated valuation allowance. At December 31, 2023, the Company had a valuation allowance of $ 137 million against various deferred tax assets related to federal and state net operating losses, capital losses and state tax credits, as the Company’s current assessment is that it is more likely than not that a portion of the deferred tax assets related to these items will not be realized. </context>
|
us-gaap:DeferredTaxAssetsValuationAllowance
|
Effective with the fiscal year ended September 30, 1997, the reserve method for bad debts was no longer permitted for tax purposes. The repeal of the reserve method required the recapture of the reserve balance in excess of certain base year reserve amounts attributable to years ended prior to 1988. At December 31, 2023, the Company’s base year loan loss reserves attributable to years ended prior to 1988, for which no deferred income taxes have been provided, was $ 557 million. This base year reserve may become taxable if certain distributions are made with respect to the stock of the Company or if CBNA ceases to qualify as a bank for tax purposes. No actions are planned that would cause any portion of this reserve to become taxable.
|
text
|
557
|
monetaryItemType
|
text: <entity> 557 </entity> <entity type> monetaryItemType </entity type> <context> Effective with the fiscal year ended September 30, 1997, the reserve method for bad debts was no longer permitted for tax purposes. The repeal of the reserve method required the recapture of the reserve balance in excess of certain base year reserve amounts attributable to years ended prior to 1988. At December 31, 2023, the Company’s base year loan loss reserves attributable to years ended prior to 1988, for which no deferred income taxes have been provided, was $ 557 million. This base year reserve may become taxable if certain distributions are made with respect to the stock of the Company or if CBNA ceases to qualify as a bank for tax purposes. No actions are planned that would cause any portion of this reserve to become taxable. </context>
|
us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsProvisionForLoanLosses
|
Interest and penalties related to unrecognized tax benefits are reported in income tax expense in the Consolidated Statements of Operations. The Company’s liability for accrued interest related to unrecognized tax benefits was $ 4 million as of December 31, 2023 and immaterial as of December 31, 2022. In addition, the income tax expense recognized for interest related to unrecognized tax benefits was $ 3 million for the year ended December 31, 2023 and immaterial for the years ended December 31, 2022 and 2021. No amounts were accrued for penalties as of December 31, 2023 and 2022, and no penalties were recognized in income tax expense during the years ended December 31, 2023, 2022 and 2021.
|
text
|
4
|
monetaryItemType
|
text: <entity> 4 </entity> <entity type> monetaryItemType </entity type> <context> Interest and penalties related to unrecognized tax benefits are reported in income tax expense in the Consolidated Statements of Operations. The Company’s liability for accrued interest related to unrecognized tax benefits was $ 4 million as of December 31, 2023 and immaterial as of December 31, 2022. In addition, the income tax expense recognized for interest related to unrecognized tax benefits was $ 3 million for the year ended December 31, 2023 and immaterial for the years ended December 31, 2022 and 2021. No amounts were accrued for penalties as of December 31, 2023 and 2022, and no penalties were recognized in income tax expense during the years ended December 31, 2023, 2022 and 2021. </context>
|
us-gaap:UnrecognizedTaxBenefitsInterestOnIncomeTaxesAccrued
|
Interest and penalties related to unrecognized tax benefits are reported in income tax expense in the Consolidated Statements of Operations. The Company’s liability for accrued interest related to unrecognized tax benefits was $ 4 million as of December 31, 2023 and immaterial as of December 31, 2022. In addition, the income tax expense recognized for interest related to unrecognized tax benefits was $ 3 million for the year ended December 31, 2023 and immaterial for the years ended December 31, 2022 and 2021. No amounts were accrued for penalties as of December 31, 2023 and 2022, and no penalties were recognized in income tax expense during the years ended December 31, 2023, 2022 and 2021.
|
text
|
3
|
monetaryItemType
|
text: <entity> 3 </entity> <entity type> monetaryItemType </entity type> <context> Interest and penalties related to unrecognized tax benefits are reported in income tax expense in the Consolidated Statements of Operations. The Company’s liability for accrued interest related to unrecognized tax benefits was $ 4 million as of December 31, 2023 and immaterial as of December 31, 2022. In addition, the income tax expense recognized for interest related to unrecognized tax benefits was $ 3 million for the year ended December 31, 2023 and immaterial for the years ended December 31, 2022 and 2021. No amounts were accrued for penalties as of December 31, 2023 and 2022, and no penalties were recognized in income tax expense during the years ended December 31, 2023, 2022 and 2021. </context>
|
us-gaap:UnrecognizedTaxBenefitsInterestOnIncomeTaxesExpense
|
Potential dilutive common shares are excluded from the computation of diluted EPS in the periods where the effect would be antidilutive. Excluded from the computation of diluted EPS were weighted-average antidilutive shares totaling 2,210,857 , 949,606 and 2,929 for the years ended December 31, 2023, 2022 and 2021, respectively.
|
text
|
2210857
|
sharesItemType
|
text: <entity> 2210857 </entity> <entity type> sharesItemType </entity type> <context> Potential dilutive common shares are excluded from the computation of diluted EPS in the periods where the effect would be antidilutive. Excluded from the computation of diluted EPS were weighted-average antidilutive shares totaling 2,210,857 , 949,606 and 2,929 for the years ended December 31, 2023, 2022 and 2021, respectively. </context>
|
us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
|
Potential dilutive common shares are excluded from the computation of diluted EPS in the periods where the effect would be antidilutive. Excluded from the computation of diluted EPS were weighted-average antidilutive shares totaling 2,210,857 , 949,606 and 2,929 for the years ended December 31, 2023, 2022 and 2021, respectively.
|
text
|
949606
|
sharesItemType
|
text: <entity> 949606 </entity> <entity type> sharesItemType </entity type> <context> Potential dilutive common shares are excluded from the computation of diluted EPS in the periods where the effect would be antidilutive. Excluded from the computation of diluted EPS were weighted-average antidilutive shares totaling 2,210,857 , 949,606 and 2,929 for the years ended December 31, 2023, 2022 and 2021, respectively. </context>
|
us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
|
Potential dilutive common shares are excluded from the computation of diluted EPS in the periods where the effect would be antidilutive. Excluded from the computation of diluted EPS were weighted-average antidilutive shares totaling 2,210,857 , 949,606 and 2,929 for the years ended December 31, 2023, 2022 and 2021, respectively.
|
text
|
2929
|
sharesItemType
|
text: <entity> 2929 </entity> <entity type> sharesItemType </entity type> <context> Potential dilutive common shares are excluded from the computation of diluted EPS in the periods where the effect would be antidilutive. Excluded from the computation of diluted EPS were weighted-average antidilutive shares totaling 2,210,857 , 949,606 and 2,929 for the years ended December 31, 2023, 2022 and 2021, respectively. </context>
|
us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
|
Citizens is managed by its Chief Executive Officer on a segment basis. The Company’s three business operating segments are Consumer Banking, Commercial Banking, and Non-Core. The business operating segments are determined based on the products and services provided, or the type of customer served. Each business operating segment has a segment head who reports directly to the Chief Executive Officer, who has final authority over resource allocation decisions and performance assessment. The business operating segments reflect this management structure and the manner in which financial information is currently evaluated by the Chief Executive Officer.
|
text
|
three
|
integerItemType
|
text: <entity> three </entity> <entity type> integerItemType </entity type> <context> Citizens is managed by its Chief Executive Officer on a segment basis. The Company’s three business operating segments are Consumer Banking, Commercial Banking, and Non-Core. The business operating segments are determined based on the products and services provided, or the type of customer served. Each business operating segment has a segment head who reports directly to the Chief Executive Officer, who has final authority over resource allocation decisions and performance assessment. The business operating segments reflect this management structure and the manner in which financial information is currently evaluated by the Chief Executive Officer. </context>
|
us-gaap:NumberOfOperatingSegments
|
The Consumer Banking segment serves consumer customers and small businesses with annual revenues of up to $ 25 million. It offers traditional banking products and services including deposits, mortgage and home equity lending, credit cards, business loans, education loans, point-of-sale finance loans, and wealth management and investment services. Citizens Private Bank, launched during 2023, integrates wealth management and banking services to serve high net-worth individuals and families, as well as businesses.
|
text
|
25
|
monetaryItemType
|
text: <entity> 25 </entity> <entity type> monetaryItemType </entity type> <context> The Consumer Banking segment serves consumer customers and small businesses with annual revenues of up to $ 25 million. It offers traditional banking products and services including deposits, mortgage and home equity lending, credit cards, business loans, education loans, point-of-sale finance loans, and wealth management and investment services. Citizens Private Bank, launched during 2023, integrates wealth management and banking services to serve high net-worth individuals and families, as well as businesses. </context>
|
us-gaap:Revenues
|
The Commercial Banking segment primarily serves companies and institutions with annual revenues of $ 25 million to more than $ 3.0 billion and strives to be a trusted advisor to its clients and preferred provider for their banking needs. A broad complement of financial products and solutions are offered, including lending and leasing, deposit and treasury management services, foreign exchange, interest rate and commodity risk management solutions, as well as syndicated loans, corporate finance, mergers and acquisitions, and debt and equity capital markets capabilities.
|
text
|
25
|
monetaryItemType
|
text: <entity> 25 </entity> <entity type> monetaryItemType </entity type> <context> The Commercial Banking segment primarily serves companies and institutions with annual revenues of $ 25 million to more than $ 3.0 billion and strives to be a trusted advisor to its clients and preferred provider for their banking needs. A broad complement of financial products and solutions are offered, including lending and leasing, deposit and treasury management services, foreign exchange, interest rate and commodity risk management solutions, as well as syndicated loans, corporate finance, mergers and acquisitions, and debt and equity capital markets capabilities. </context>
|
us-gaap:Revenues
|
The Commercial Banking segment primarily serves companies and institutions with annual revenues of $ 25 million to more than $ 3.0 billion and strives to be a trusted advisor to its clients and preferred provider for their banking needs. A broad complement of financial products and solutions are offered, including lending and leasing, deposit and treasury management services, foreign exchange, interest rate and commodity risk management solutions, as well as syndicated loans, corporate finance, mergers and acquisitions, and debt and equity capital markets capabilities.
|
text
|
3.0
|
monetaryItemType
|
text: <entity> 3.0 </entity> <entity type> monetaryItemType </entity type> <context> The Commercial Banking segment primarily serves companies and institutions with annual revenues of $ 25 million to more than $ 3.0 billion and strives to be a trusted advisor to its clients and preferred provider for their banking needs. A broad complement of financial products and solutions are offered, including lending and leasing, deposit and treasury management services, foreign exchange, interest rate and commodity risk management solutions, as well as syndicated loans, corporate finance, mergers and acquisitions, and debt and equity capital markets capabilities. </context>
|
us-gaap:Revenues
|
Subsequently, we manage our operating results through four operating segments. We have two reportable segments defined by geographic region: North America and International Developed Markets. Our remaining operating segments, consisting of WEEM and AEM, are combined and disclosed as Emerging Markets.
|
text
|
four
|
integerItemType
|
text: <entity> four </entity> <entity type> integerItemType </entity type> <context> Subsequently, we manage our operating results through four operating segments. We have two reportable segments defined by geographic region: North America and International Developed Markets. Our remaining operating segments, consisting of WEEM and AEM, are combined and disclosed as Emerging Markets. </context>
|
us-gaap:NumberOfOperatingSegments
|
Subsequently, we manage our operating results through four operating segments. We have two reportable segments defined by geographic region: North America and International Developed Markets. Our remaining operating segments, consisting of WEEM and AEM, are combined and disclosed as Emerging Markets.
|
text
|
two
|
integerItemType
|
text: <entity> two </entity> <entity type> integerItemType </entity type> <context> Subsequently, we manage our operating results through four operating segments. We have two reportable segments defined by geographic region: North America and International Developed Markets. Our remaining operating segments, consisting of WEEM and AEM, are combined and disclosed as Emerging Markets. </context>
|
us-gaap:NumberOfReportableSegments
|
Cash equivalents include term deposits with banks, money market funds, and all highly liquid investments with original maturities of three months or less. The fair value of cash equivalents approximates the carrying amount. Cash and cash equivalents that are legally restricted as to withdrawal or usage are classified in other current assets or other non-current assets, as applicable, on the consolidated balance sheets. At December 28, 2024, we had restricted cash of $ 31 million recorded in other current assets and restricted cash of $ 121 million recorded in other non-current assets. At December 30, 2023, we had restricted cash of $ 3 million recorded in other current assets and restricted cash of $ 1 million recorded in other non-current assets. The year-over-year increase was due to the conversion of certain assets related to the U.S. postretirement medical plan to cash. See Note 11,
|
text
|
31
|
monetaryItemType
|
text: <entity> 31 </entity> <entity type> monetaryItemType </entity type> <context> Cash equivalents include term deposits with banks, money market funds, and all highly liquid investments with original maturities of three months or less. The fair value of cash equivalents approximates the carrying amount. Cash and cash equivalents that are legally restricted as to withdrawal or usage are classified in other current assets or other non-current assets, as applicable, on the consolidated balance sheets. At December 28, 2024, we had restricted cash of $ 31 million recorded in other current assets and restricted cash of $ 121 million recorded in other non-current assets. At December 30, 2023, we had restricted cash of $ 3 million recorded in other current assets and restricted cash of $ 1 million recorded in other non-current assets. The year-over-year increase was due to the conversion of certain assets related to the U.S. postretirement medical plan to cash. See Note 11, </context>
|
us-gaap:RestrictedCashAndCashEquivalentsAtCarryingValue
|
Cash equivalents include term deposits with banks, money market funds, and all highly liquid investments with original maturities of three months or less. The fair value of cash equivalents approximates the carrying amount. Cash and cash equivalents that are legally restricted as to withdrawal or usage are classified in other current assets or other non-current assets, as applicable, on the consolidated balance sheets. At December 28, 2024, we had restricted cash of $ 31 million recorded in other current assets and restricted cash of $ 121 million recorded in other non-current assets. At December 30, 2023, we had restricted cash of $ 3 million recorded in other current assets and restricted cash of $ 1 million recorded in other non-current assets. The year-over-year increase was due to the conversion of certain assets related to the U.S. postretirement medical plan to cash. See Note 11,
|
text
|
121
|
monetaryItemType
|
text: <entity> 121 </entity> <entity type> monetaryItemType </entity type> <context> Cash equivalents include term deposits with banks, money market funds, and all highly liquid investments with original maturities of three months or less. The fair value of cash equivalents approximates the carrying amount. Cash and cash equivalents that are legally restricted as to withdrawal or usage are classified in other current assets or other non-current assets, as applicable, on the consolidated balance sheets. At December 28, 2024, we had restricted cash of $ 31 million recorded in other current assets and restricted cash of $ 121 million recorded in other non-current assets. At December 30, 2023, we had restricted cash of $ 3 million recorded in other current assets and restricted cash of $ 1 million recorded in other non-current assets. The year-over-year increase was due to the conversion of certain assets related to the U.S. postretirement medical plan to cash. See Note 11, </context>
|
us-gaap:RestrictedCashAndCashEquivalentsNoncurrent
|
Cash equivalents include term deposits with banks, money market funds, and all highly liquid investments with original maturities of three months or less. The fair value of cash equivalents approximates the carrying amount. Cash and cash equivalents that are legally restricted as to withdrawal or usage are classified in other current assets or other non-current assets, as applicable, on the consolidated balance sheets. At December 28, 2024, we had restricted cash of $ 31 million recorded in other current assets and restricted cash of $ 121 million recorded in other non-current assets. At December 30, 2023, we had restricted cash of $ 3 million recorded in other current assets and restricted cash of $ 1 million recorded in other non-current assets. The year-over-year increase was due to the conversion of certain assets related to the U.S. postretirement medical plan to cash. See Note 11,
|
text
|
3
|
monetaryItemType
|
text: <entity> 3 </entity> <entity type> monetaryItemType </entity type> <context> Cash equivalents include term deposits with banks, money market funds, and all highly liquid investments with original maturities of three months or less. The fair value of cash equivalents approximates the carrying amount. Cash and cash equivalents that are legally restricted as to withdrawal or usage are classified in other current assets or other non-current assets, as applicable, on the consolidated balance sheets. At December 28, 2024, we had restricted cash of $ 31 million recorded in other current assets and restricted cash of $ 121 million recorded in other non-current assets. At December 30, 2023, we had restricted cash of $ 3 million recorded in other current assets and restricted cash of $ 1 million recorded in other non-current assets. The year-over-year increase was due to the conversion of certain assets related to the U.S. postretirement medical plan to cash. See Note 11, </context>
|
us-gaap:RestrictedCashAndCashEquivalentsAtCarryingValue
|
Cash equivalents include term deposits with banks, money market funds, and all highly liquid investments with original maturities of three months or less. The fair value of cash equivalents approximates the carrying amount. Cash and cash equivalents that are legally restricted as to withdrawal or usage are classified in other current assets or other non-current assets, as applicable, on the consolidated balance sheets. At December 28, 2024, we had restricted cash of $ 31 million recorded in other current assets and restricted cash of $ 121 million recorded in other non-current assets. At December 30, 2023, we had restricted cash of $ 3 million recorded in other current assets and restricted cash of $ 1 million recorded in other non-current assets. The year-over-year increase was due to the conversion of certain assets related to the U.S. postretirement medical plan to cash. See Note 11,
|
text
|
1
|
monetaryItemType
|
text: <entity> 1 </entity> <entity type> monetaryItemType </entity type> <context> Cash equivalents include term deposits with banks, money market funds, and all highly liquid investments with original maturities of three months or less. The fair value of cash equivalents approximates the carrying amount. Cash and cash equivalents that are legally restricted as to withdrawal or usage are classified in other current assets or other non-current assets, as applicable, on the consolidated balance sheets. At December 28, 2024, we had restricted cash of $ 31 million recorded in other current assets and restricted cash of $ 121 million recorded in other non-current assets. At December 30, 2023, we had restricted cash of $ 3 million recorded in other current assets and restricted cash of $ 1 million recorded in other non-current assets. The year-over-year increase was due to the conversion of certain assets related to the U.S. postretirement medical plan to cash. See Note 11, </context>
|
us-gaap:RestrictedCashAndCashEquivalentsNoncurrent
|
, for additional information. Total cash, cash equivalents, and restricted cash was $ 1,486 million at December 28, 2024 and $ 1,404 million at December 30, 2023.
|
text
|
1486
|
monetaryItemType
|
text: <entity> 1486 </entity> <entity type> monetaryItemType </entity type> <context> , for additional information. Total cash, cash equivalents, and restricted cash was $ 1,486 million at December 28, 2024 and $ 1,404 million at December 30, 2023. </context>
|
us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
, for additional information. Total cash, cash equivalents, and restricted cash was $ 1,486 million at December 28, 2024 and $ 1,404 million at December 30, 2023.
|
text
|
1404
|
monetaryItemType
|
text: <entity> 1404 </entity> <entity type> monetaryItemType </entity type> <context> , for additional information. Total cash, cash equivalents, and restricted cash was $ 1,486 million at December 28, 2024 and $ 1,404 million at December 30, 2023. </context>
|
us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
Advertising expenses are recorded in selling, general and administrative expenses (“SG&A”). For interim reporting purposes, we charge advertising to operations as a percentage of estimated full year sales activity and marketing costs. We then review and adjust these estimates each quarter based on actual experience and other information. Our definition of advertising expenses includes advertising production costs, in-store advertising costs, agency fees, brand promotions and events, and sponsorships, in addition to costs to obtain advertising in television, radio, print, digital, and social channels. We recorded advertising expenses of $ 1,031 million in 2024, $ 1,071 million in 2023, and $ 945 million in 2022. We also incur market research costs, which are recorded in SG&A but are excluded from advertising expenses.
|
text
|
1031
|
monetaryItemType
|
text: <entity> 1031 </entity> <entity type> monetaryItemType </entity type> <context> Advertising expenses are recorded in selling, general and administrative expenses (“SG&A”). For interim reporting purposes, we charge advertising to operations as a percentage of estimated full year sales activity and marketing costs. We then review and adjust these estimates each quarter based on actual experience and other information. Our definition of advertising expenses includes advertising production costs, in-store advertising costs, agency fees, brand promotions and events, and sponsorships, in addition to costs to obtain advertising in television, radio, print, digital, and social channels. We recorded advertising expenses of $ 1,031 million in 2024, $ 1,071 million in 2023, and $ 945 million in 2022. We also incur market research costs, which are recorded in SG&A but are excluded from advertising expenses. </context>
|
us-gaap:AdvertisingExpense
|
Advertising expenses are recorded in selling, general and administrative expenses (“SG&A”). For interim reporting purposes, we charge advertising to operations as a percentage of estimated full year sales activity and marketing costs. We then review and adjust these estimates each quarter based on actual experience and other information. Our definition of advertising expenses includes advertising production costs, in-store advertising costs, agency fees, brand promotions and events, and sponsorships, in addition to costs to obtain advertising in television, radio, print, digital, and social channels. We recorded advertising expenses of $ 1,031 million in 2024, $ 1,071 million in 2023, and $ 945 million in 2022. We also incur market research costs, which are recorded in SG&A but are excluded from advertising expenses.
|
text
|
1071
|
monetaryItemType
|
text: <entity> 1071 </entity> <entity type> monetaryItemType </entity type> <context> Advertising expenses are recorded in selling, general and administrative expenses (“SG&A”). For interim reporting purposes, we charge advertising to operations as a percentage of estimated full year sales activity and marketing costs. We then review and adjust these estimates each quarter based on actual experience and other information. Our definition of advertising expenses includes advertising production costs, in-store advertising costs, agency fees, brand promotions and events, and sponsorships, in addition to costs to obtain advertising in television, radio, print, digital, and social channels. We recorded advertising expenses of $ 1,031 million in 2024, $ 1,071 million in 2023, and $ 945 million in 2022. We also incur market research costs, which are recorded in SG&A but are excluded from advertising expenses. </context>
|
us-gaap:AdvertisingExpense
|
Advertising expenses are recorded in selling, general and administrative expenses (“SG&A”). For interim reporting purposes, we charge advertising to operations as a percentage of estimated full year sales activity and marketing costs. We then review and adjust these estimates each quarter based on actual experience and other information. Our definition of advertising expenses includes advertising production costs, in-store advertising costs, agency fees, brand promotions and events, and sponsorships, in addition to costs to obtain advertising in television, radio, print, digital, and social channels. We recorded advertising expenses of $ 1,031 million in 2024, $ 1,071 million in 2023, and $ 945 million in 2022. We also incur market research costs, which are recorded in SG&A but are excluded from advertising expenses.
|
text
|
945
|
monetaryItemType
|
text: <entity> 945 </entity> <entity type> monetaryItemType </entity type> <context> Advertising expenses are recorded in selling, general and administrative expenses (“SG&A”). For interim reporting purposes, we charge advertising to operations as a percentage of estimated full year sales activity and marketing costs. We then review and adjust these estimates each quarter based on actual experience and other information. Our definition of advertising expenses includes advertising production costs, in-store advertising costs, agency fees, brand promotions and events, and sponsorships, in addition to costs to obtain advertising in television, radio, print, digital, and social channels. We recorded advertising expenses of $ 1,031 million in 2024, $ 1,071 million in 2023, and $ 945 million in 2022. We also incur market research costs, which are recorded in SG&A but are excluded from advertising expenses. </context>
|
us-gaap:AdvertisingExpense
|
trademarks, for a total consideration of approximately $ 3.3 billion. Of the $ 3.3 billion total consideration, approximately $ 1.6 billion was attributed to the licensing of the
|
text
|
3.3
|
monetaryItemType
|
text: <entity> 3.3 </entity> <entity type> monetaryItemType </entity type> <context> trademarks, for a total consideration of approximately $ 3.3 billion. Of the $ 3.3 billion total consideration, approximately $ 1.6 billion was attributed to the licensing of the </context>
|
us-gaap:DisposalGroupIncludingDiscontinuedOperationConsideration
|
trademarks, for a total consideration of approximately $ 3.3 billion. Of the $ 3.3 billion total consideration, approximately $ 1.6 billion was attributed to the licensing of the
|
text
|
1.6
|
monetaryItemType
|
text: <entity> 1.6 </entity> <entity type> monetaryItemType </entity type> <context> trademarks, for a total consideration of approximately $ 3.3 billion. Of the $ 3.3 billion total consideration, approximately $ 1.6 billion was attributed to the licensing of the </context>
|
us-gaap:DisposalGroupIncludingDiscontinuedOperationIntangibleAssets
|
brand was recognized over a period of approximately three years . We recognized license income of approximately $ 54 million in 2024 and 2023, and $ 56 million in 2022, which is recorded as a reduction to SG&A. Related to this agreement, we have recorded approximately $ 1.4 billion in long-term deferred income and $ 54 million in other current liabilities at December 28, 2024, and $ 1.4 billion in long-term deferred income and $ 55 million in other current liabilities at December 30, 2023 on the consolidated balance sheet.
|
text
|
1.4
|
monetaryItemType
|
text: <entity> 1.4 </entity> <entity type> monetaryItemType </entity type> <context> brand was recognized over a period of approximately three years . We recognized license income of approximately $ 54 million in 2024 and 2023, and $ 56 million in 2022, which is recorded as a reduction to SG&A. Related to this agreement, we have recorded approximately $ 1.4 billion in long-term deferred income and $ 54 million in other current liabilities at December 28, 2024, and $ 1.4 billion in long-term deferred income and $ 55 million in other current liabilities at December 30, 2023 on the consolidated balance sheet. </context>
|
us-gaap:DeferredIncomeNoncurrent
|
brand was recognized over a period of approximately three years . We recognized license income of approximately $ 54 million in 2024 and 2023, and $ 56 million in 2022, which is recorded as a reduction to SG&A. Related to this agreement, we have recorded approximately $ 1.4 billion in long-term deferred income and $ 54 million in other current liabilities at December 28, 2024, and $ 1.4 billion in long-term deferred income and $ 55 million in other current liabilities at December 30, 2023 on the consolidated balance sheet.
|
text
|
54
|
monetaryItemType
|
text: <entity> 54 </entity> <entity type> monetaryItemType </entity type> <context> brand was recognized over a period of approximately three years . We recognized license income of approximately $ 54 million in 2024 and 2023, and $ 56 million in 2022, which is recorded as a reduction to SG&A. Related to this agreement, we have recorded approximately $ 1.4 billion in long-term deferred income and $ 54 million in other current liabilities at December 28, 2024, and $ 1.4 billion in long-term deferred income and $ 55 million in other current liabilities at December 30, 2023 on the consolidated balance sheet. </context>
|
us-gaap:OtherLiabilitiesCurrent
|
brand was recognized over a period of approximately three years . We recognized license income of approximately $ 54 million in 2024 and 2023, and $ 56 million in 2022, which is recorded as a reduction to SG&A. Related to this agreement, we have recorded approximately $ 1.4 billion in long-term deferred income and $ 54 million in other current liabilities at December 28, 2024, and $ 1.4 billion in long-term deferred income and $ 55 million in other current liabilities at December 30, 2023 on the consolidated balance sheet.
|
text
|
55
|
monetaryItemType
|
text: <entity> 55 </entity> <entity type> monetaryItemType </entity type> <context> brand was recognized over a period of approximately three years . We recognized license income of approximately $ 54 million in 2024 and 2023, and $ 56 million in 2022, which is recorded as a reduction to SG&A. Related to this agreement, we have recorded approximately $ 1.4 billion in long-term deferred income and $ 54 million in other current liabilities at December 28, 2024, and $ 1.4 billion in long-term deferred income and $ 55 million in other current liabilities at December 30, 2023 on the consolidated balance sheet. </context>
|
us-gaap:OtherLiabilitiesCurrent
|
We maintain 12 reporting units, eight of which comprise our goodwill balance. Our indefinite-lived intangible asset balance primarily consists of a number of individual brands. We test our reporting units and brands for impairment annually as of the first day of our third quarter, or more frequently if events or circumstances indicate it is more likely than not that the fair value of a reporting unit or brand is less than its carrying amount. Such events and circumstances could include a sustained decrease in our market capitalization, increased competition or unexpected loss of market share, increased input costs beyond projections, disposals of significant brands or components of our business, unexpected business disruptions (for example due to a natural disaster, pandemic, or loss of a customer, supplier, or other significant business relationship), unexpected significant declines in operating results, significant adverse changes in the markets in which we operate, changes in income tax rates, changes in interest rates, or changes in management strategy. We test reporting units for impairment by comparing the estimated fair value of each reporting unit with its carrying amount. We test brands for impairment by comparing the estimated fair value of each brand with its carrying amount. If the carrying amount of a reporting unit or brand exceeds its estimated fair value, we record an impairment loss based on the difference between fair value and carrying amount, in the case of reporting units, not to exceed the associated carrying amount of goodwill.
|
text
|
12
|
integerItemType
|
text: <entity> 12 </entity> <entity type> integerItemType </entity type> <context> We maintain 12 reporting units, eight of which comprise our goodwill balance. Our indefinite-lived intangible asset balance primarily consists of a number of individual brands. We test our reporting units and brands for impairment annually as of the first day of our third quarter, or more frequently if events or circumstances indicate it is more likely than not that the fair value of a reporting unit or brand is less than its carrying amount. Such events and circumstances could include a sustained decrease in our market capitalization, increased competition or unexpected loss of market share, increased input costs beyond projections, disposals of significant brands or components of our business, unexpected business disruptions (for example due to a natural disaster, pandemic, or loss of a customer, supplier, or other significant business relationship), unexpected significant declines in operating results, significant adverse changes in the markets in which we operate, changes in income tax rates, changes in interest rates, or changes in management strategy. We test reporting units for impairment by comparing the estimated fair value of each reporting unit with its carrying amount. We test brands for impairment by comparing the estimated fair value of each brand with its carrying amount. If the carrying amount of a reporting unit or brand exceeds its estimated fair value, we record an impairment loss based on the difference between fair value and carrying amount, in the case of reporting units, not to exceed the associated carrying amount of goodwill. </context>
|
us-gaap:NumberOfReportingUnits
|
We maintain 12 reporting units, eight of which comprise our goodwill balance. Our indefinite-lived intangible asset balance primarily consists of a number of individual brands. We test our reporting units and brands for impairment annually as of the first day of our third quarter, or more frequently if events or circumstances indicate it is more likely than not that the fair value of a reporting unit or brand is less than its carrying amount. Such events and circumstances could include a sustained decrease in our market capitalization, increased competition or unexpected loss of market share, increased input costs beyond projections, disposals of significant brands or components of our business, unexpected business disruptions (for example due to a natural disaster, pandemic, or loss of a customer, supplier, or other significant business relationship), unexpected significant declines in operating results, significant adverse changes in the markets in which we operate, changes in income tax rates, changes in interest rates, or changes in management strategy. We test reporting units for impairment by comparing the estimated fair value of each reporting unit with its carrying amount. We test brands for impairment by comparing the estimated fair value of each brand with its carrying amount. If the carrying amount of a reporting unit or brand exceeds its estimated fair value, we record an impairment loss based on the difference between fair value and carrying amount, in the case of reporting units, not to exceed the associated carrying amount of goodwill.
|
text
|
eight
|
integerItemType
|
text: <entity> eight </entity> <entity type> integerItemType </entity type> <context> We maintain 12 reporting units, eight of which comprise our goodwill balance. Our indefinite-lived intangible asset balance primarily consists of a number of individual brands. We test our reporting units and brands for impairment annually as of the first day of our third quarter, or more frequently if events or circumstances indicate it is more likely than not that the fair value of a reporting unit or brand is less than its carrying amount. Such events and circumstances could include a sustained decrease in our market capitalization, increased competition or unexpected loss of market share, increased input costs beyond projections, disposals of significant brands or components of our business, unexpected business disruptions (for example due to a natural disaster, pandemic, or loss of a customer, supplier, or other significant business relationship), unexpected significant declines in operating results, significant adverse changes in the markets in which we operate, changes in income tax rates, changes in interest rates, or changes in management strategy. We test reporting units for impairment by comparing the estimated fair value of each reporting unit with its carrying amount. We test brands for impairment by comparing the estimated fair value of each brand with its carrying amount. If the carrying amount of a reporting unit or brand exceeds its estimated fair value, we record an impairment loss based on the difference between fair value and carrying amount, in the case of reporting units, not to exceed the associated carrying amount of goodwill. </context>
|
us-gaap:NumberOfReportingUnits
|
The Hemmer Acquisition was accounted for under the acquisition method of accounting for business combinations. Total cash consideration related to the Hemmer Acquisition was approximately 1.3 billion Brazilian reais (approximately $ 279 million at the Hemmer Acquisition Date). A noncontrolling interest was recognized at fair value, which was determined to be the noncontrolling interest’s proportionate share of the acquiree’s identifiable net assets, as of the Hemmer Acquisition Date. As of the Hemmer Acquisition Date, we acquired 94 % of the outstanding shares of Hemmer. In the third quarter of 2022, we completed the redemption of the remaining outstanding shares and own 100 % of the controlling interest in Hemmer.
|
text
|
1.3
|
monetaryItemType
|
text: <entity> 1.3 </entity> <entity type> monetaryItemType </entity type> <context> The Hemmer Acquisition was accounted for under the acquisition method of accounting for business combinations. Total cash consideration related to the Hemmer Acquisition was approximately 1.3 billion Brazilian reais (approximately $ 279 million at the Hemmer Acquisition Date). A noncontrolling interest was recognized at fair value, which was determined to be the noncontrolling interest’s proportionate share of the acquiree’s identifiable net assets, as of the Hemmer Acquisition Date. As of the Hemmer Acquisition Date, we acquired 94 % of the outstanding shares of Hemmer. In the third quarter of 2022, we completed the redemption of the remaining outstanding shares and own 100 % of the controlling interest in Hemmer. </context>
|
us-gaap:PaymentsToAcquireBusinessesGross
|
The Hemmer Acquisition was accounted for under the acquisition method of accounting for business combinations. Total cash consideration related to the Hemmer Acquisition was approximately 1.3 billion Brazilian reais (approximately $ 279 million at the Hemmer Acquisition Date). A noncontrolling interest was recognized at fair value, which was determined to be the noncontrolling interest’s proportionate share of the acquiree’s identifiable net assets, as of the Hemmer Acquisition Date. As of the Hemmer Acquisition Date, we acquired 94 % of the outstanding shares of Hemmer. In the third quarter of 2022, we completed the redemption of the remaining outstanding shares and own 100 % of the controlling interest in Hemmer.
|
text
|
279
|
monetaryItemType
|
text: <entity> 279 </entity> <entity type> monetaryItemType </entity type> <context> The Hemmer Acquisition was accounted for under the acquisition method of accounting for business combinations. Total cash consideration related to the Hemmer Acquisition was approximately 1.3 billion Brazilian reais (approximately $ 279 million at the Hemmer Acquisition Date). A noncontrolling interest was recognized at fair value, which was determined to be the noncontrolling interest’s proportionate share of the acquiree’s identifiable net assets, as of the Hemmer Acquisition Date. As of the Hemmer Acquisition Date, we acquired 94 % of the outstanding shares of Hemmer. In the third quarter of 2022, we completed the redemption of the remaining outstanding shares and own 100 % of the controlling interest in Hemmer. </context>
|
us-gaap:PaymentsToAcquireBusinessesGross
|
The Hemmer Acquisition was accounted for under the acquisition method of accounting for business combinations. Total cash consideration related to the Hemmer Acquisition was approximately 1.3 billion Brazilian reais (approximately $ 279 million at the Hemmer Acquisition Date). A noncontrolling interest was recognized at fair value, which was determined to be the noncontrolling interest’s proportionate share of the acquiree’s identifiable net assets, as of the Hemmer Acquisition Date. As of the Hemmer Acquisition Date, we acquired 94 % of the outstanding shares of Hemmer. In the third quarter of 2022, we completed the redemption of the remaining outstanding shares and own 100 % of the controlling interest in Hemmer.
|
text
|
94
|
percentItemType
|
text: <entity> 94 </entity> <entity type> percentItemType </entity type> <context> The Hemmer Acquisition was accounted for under the acquisition method of accounting for business combinations. Total cash consideration related to the Hemmer Acquisition was approximately 1.3 billion Brazilian reais (approximately $ 279 million at the Hemmer Acquisition Date). A noncontrolling interest was recognized at fair value, which was determined to be the noncontrolling interest’s proportionate share of the acquiree’s identifiable net assets, as of the Hemmer Acquisition Date. As of the Hemmer Acquisition Date, we acquired 94 % of the outstanding shares of Hemmer. In the third quarter of 2022, we completed the redemption of the remaining outstanding shares and own 100 % of the controlling interest in Hemmer. </context>
|
us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired
|
The Hemmer Acquisition was accounted for under the acquisition method of accounting for business combinations. Total cash consideration related to the Hemmer Acquisition was approximately 1.3 billion Brazilian reais (approximately $ 279 million at the Hemmer Acquisition Date). A noncontrolling interest was recognized at fair value, which was determined to be the noncontrolling interest’s proportionate share of the acquiree’s identifiable net assets, as of the Hemmer Acquisition Date. As of the Hemmer Acquisition Date, we acquired 94 % of the outstanding shares of Hemmer. In the third quarter of 2022, we completed the redemption of the remaining outstanding shares and own 100 % of the controlling interest in Hemmer.
|
text
|
100
|
percentItemType
|
text: <entity> 100 </entity> <entity type> percentItemType </entity type> <context> The Hemmer Acquisition was accounted for under the acquisition method of accounting for business combinations. Total cash consideration related to the Hemmer Acquisition was approximately 1.3 billion Brazilian reais (approximately $ 279 million at the Hemmer Acquisition Date). A noncontrolling interest was recognized at fair value, which was determined to be the noncontrolling interest’s proportionate share of the acquiree’s identifiable net assets, as of the Hemmer Acquisition Date. As of the Hemmer Acquisition Date, we acquired 94 % of the outstanding shares of Hemmer. In the third quarter of 2022, we completed the redemption of the remaining outstanding shares and own 100 % of the controlling interest in Hemmer. </context>
|
us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired
|
The Hemmer Acquisition preliminarily resulted in $ 219 million of non-tax deductible goodwill relating principally to Hemmer’s long-term experience and large presence operating in emerging markets. This goodwill was assigned to the Latin America (“LATAM”) reporting unit within Emerging Markets. In 2022, certain insignificant measurement period adjustments were made to the initial allocation, and the final amount of goodwill was adjusted to $ 215 million. In the fourth quarter of 2022, a portion of the goodwill became tax deductible following the merger of Hemmer into our existing legal entity structure. As part of our 2024 annual impairment test, we fully impaired the goodwill related to our LATAM reporting unit, and there is no goodwill carrying value remaining as of December 28, 2024. See Note 8,
|
text
|
219
|
monetaryItemType
|
text: <entity> 219 </entity> <entity type> monetaryItemType </entity type> <context> The Hemmer Acquisition preliminarily resulted in $ 219 million of non-tax deductible goodwill relating principally to Hemmer’s long-term experience and large presence operating in emerging markets. This goodwill was assigned to the Latin America (“LATAM”) reporting unit within Emerging Markets. In 2022, certain insignificant measurement period adjustments were made to the initial allocation, and the final amount of goodwill was adjusted to $ 215 million. In the fourth quarter of 2022, a portion of the goodwill became tax deductible following the merger of Hemmer into our existing legal entity structure. As part of our 2024 annual impairment test, we fully impaired the goodwill related to our LATAM reporting unit, and there is no goodwill carrying value remaining as of December 28, 2024. See Note 8, </context>
|
us-gaap:Goodwill
|
The Hemmer Acquisition preliminarily resulted in $ 219 million of non-tax deductible goodwill relating principally to Hemmer’s long-term experience and large presence operating in emerging markets. This goodwill was assigned to the Latin America (“LATAM”) reporting unit within Emerging Markets. In 2022, certain insignificant measurement period adjustments were made to the initial allocation, and the final amount of goodwill was adjusted to $ 215 million. In the fourth quarter of 2022, a portion of the goodwill became tax deductible following the merger of Hemmer into our existing legal entity structure. As part of our 2024 annual impairment test, we fully impaired the goodwill related to our LATAM reporting unit, and there is no goodwill carrying value remaining as of December 28, 2024. See Note 8,
|
text
|
215
|
monetaryItemType
|
text: <entity> 215 </entity> <entity type> monetaryItemType </entity type> <context> The Hemmer Acquisition preliminarily resulted in $ 219 million of non-tax deductible goodwill relating principally to Hemmer’s long-term experience and large presence operating in emerging markets. This goodwill was assigned to the Latin America (“LATAM”) reporting unit within Emerging Markets. In 2022, certain insignificant measurement period adjustments were made to the initial allocation, and the final amount of goodwill was adjusted to $ 215 million. In the fourth quarter of 2022, a portion of the goodwill became tax deductible following the merger of Hemmer into our existing legal entity structure. As part of our 2024 annual impairment test, we fully impaired the goodwill related to our LATAM reporting unit, and there is no goodwill carrying value remaining as of December 28, 2024. See Note 8, </context>
|
us-gaap:Goodwill
|
On January 18, 2022 (the “Just Spices Acquisition Date”), we acquired 85 % of the shares of Just Spices GmbH (“Just Spices”), a German-based company focused on direct-to-consumer sales of premium spice blends, from certain third-party shareholders (the “Just Spices Acquisition”).
|
text
|
85
|
percentItemType
|
text: <entity> 85 </entity> <entity type> percentItemType </entity type> <context> On January 18, 2022 (the “Just Spices Acquisition Date”), we acquired 85 % of the shares of Just Spices GmbH (“Just Spices”), a German-based company focused on direct-to-consumer sales of premium spice blends, from certain third-party shareholders (the “Just Spices Acquisition”). </context>
|
us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired
|
The Just Spices Acquisition was accounted for under the acquisition method of accounting for business combinations. Total cash consideration related to the Just Spices Acquisition was approximately 214 million euros (approximately $ 243 million at the Just Spices Acquisition Date). A noncontrolling interest was recognized at fair value, which was determined to be the noncontrolling interest’s proportionate share of the acquiree’s identifiable net assets, as of the Just Spices Acquisition Date. Under the terms of certain transaction agreements, Just Spices’ other equity holders each have a put option to require us to purchase the remaining equity interests beginning three years after the Just Spices Acquisition Date. If the put option is not exercised, we have a call option to acquire the remaining equity interests of Just Spices. Considering the contractual terms related to the noncontrolling interest, it is classified as redeemable noncontrolling interest on our consolidated balance sheet.
|
text
|
214
|
monetaryItemType
|
text: <entity> 214 </entity> <entity type> monetaryItemType </entity type> <context> The Just Spices Acquisition was accounted for under the acquisition method of accounting for business combinations. Total cash consideration related to the Just Spices Acquisition was approximately 214 million euros (approximately $ 243 million at the Just Spices Acquisition Date). A noncontrolling interest was recognized at fair value, which was determined to be the noncontrolling interest’s proportionate share of the acquiree’s identifiable net assets, as of the Just Spices Acquisition Date. Under the terms of certain transaction agreements, Just Spices’ other equity holders each have a put option to require us to purchase the remaining equity interests beginning three years after the Just Spices Acquisition Date. If the put option is not exercised, we have a call option to acquire the remaining equity interests of Just Spices. Considering the contractual terms related to the noncontrolling interest, it is classified as redeemable noncontrolling interest on our consolidated balance sheet. </context>
|
us-gaap:PaymentsToAcquireBusinessesGross
|
The Just Spices Acquisition was accounted for under the acquisition method of accounting for business combinations. Total cash consideration related to the Just Spices Acquisition was approximately 214 million euros (approximately $ 243 million at the Just Spices Acquisition Date). A noncontrolling interest was recognized at fair value, which was determined to be the noncontrolling interest’s proportionate share of the acquiree’s identifiable net assets, as of the Just Spices Acquisition Date. Under the terms of certain transaction agreements, Just Spices’ other equity holders each have a put option to require us to purchase the remaining equity interests beginning three years after the Just Spices Acquisition Date. If the put option is not exercised, we have a call option to acquire the remaining equity interests of Just Spices. Considering the contractual terms related to the noncontrolling interest, it is classified as redeemable noncontrolling interest on our consolidated balance sheet.
|
text
|
243
|
monetaryItemType
|
text: <entity> 243 </entity> <entity type> monetaryItemType </entity type> <context> The Just Spices Acquisition was accounted for under the acquisition method of accounting for business combinations. Total cash consideration related to the Just Spices Acquisition was approximately 214 million euros (approximately $ 243 million at the Just Spices Acquisition Date). A noncontrolling interest was recognized at fair value, which was determined to be the noncontrolling interest’s proportionate share of the acquiree’s identifiable net assets, as of the Just Spices Acquisition Date. Under the terms of certain transaction agreements, Just Spices’ other equity holders each have a put option to require us to purchase the remaining equity interests beginning three years after the Just Spices Acquisition Date. If the put option is not exercised, we have a call option to acquire the remaining equity interests of Just Spices. Considering the contractual terms related to the noncontrolling interest, it is classified as redeemable noncontrolling interest on our consolidated balance sheet. </context>
|
us-gaap:PaymentsToAcquireBusinessesGross
|
Subsequent to the Just Spices Acquisition, the redeemable noncontrolling interest is measured at the greater of the amount that would be paid if settlement occurred as of the balance sheet date based on the contractually defined redemption value and its carrying amount adjusted for the net income/(loss) attributable to the noncontrolling interest. In the third quarter of 2023, we completed the redemption of an additional 5 % of the outstanding shares. In the second quarter of 2024, we completed the redemption of the remaining outstanding shares and wholly own Just Spices as of December 28, 2024. We utilized fair values at the Just Spices Acquisition Date to allocate the total consideration exchanged to the net tangible and intangible assets acquired and liabilities assumed. The purchase price allocation for the Just Spices Acquisition was final as of the fourth quarter of 2022.
|
text
|
5
|
percentItemType
|
text: <entity> 5 </entity> <entity type> percentItemType </entity type> <context> Subsequent to the Just Spices Acquisition, the redeemable noncontrolling interest is measured at the greater of the amount that would be paid if settlement occurred as of the balance sheet date based on the contractually defined redemption value and its carrying amount adjusted for the net income/(loss) attributable to the noncontrolling interest. In the third quarter of 2023, we completed the redemption of an additional 5 % of the outstanding shares. In the second quarter of 2024, we completed the redemption of the remaining outstanding shares and wholly own Just Spices as of December 28, 2024. We utilized fair values at the Just Spices Acquisition Date to allocate the total consideration exchanged to the net tangible and intangible assets acquired and liabilities assumed. The purchase price allocation for the Just Spices Acquisition was final as of the fourth quarter of 2022. </context>
|
us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired
|
The Just Spices Acquisition preliminarily resulted in $ 167 million of non-tax deductible goodwill relating principally to Just Spices’ social media presence. This goodwill was assigned to the Continental Europe reporting unit within our International Developed Markets segment. In 2022, certain insignificant measurement period adjustments were made to the initial allocation, and the final amount of goodwill was adjusted to $ 156 million. See Note 8,
|
text
|
167
|
monetaryItemType
|
text: <entity> 167 </entity> <entity type> monetaryItemType </entity type> <context> The Just Spices Acquisition preliminarily resulted in $ 167 million of non-tax deductible goodwill relating principally to Just Spices’ social media presence. This goodwill was assigned to the Continental Europe reporting unit within our International Developed Markets segment. In 2022, certain insignificant measurement period adjustments were made to the initial allocation, and the final amount of goodwill was adjusted to $ 156 million. See Note 8, </context>
|
us-gaap:Goodwill
|
The Just Spices Acquisition preliminarily resulted in $ 167 million of non-tax deductible goodwill relating principally to Just Spices’ social media presence. This goodwill was assigned to the Continental Europe reporting unit within our International Developed Markets segment. In 2022, certain insignificant measurement period adjustments were made to the initial allocation, and the final amount of goodwill was adjusted to $ 156 million. See Note 8,
|
text
|
156
|
monetaryItemType
|
text: <entity> 156 </entity> <entity type> monetaryItemType </entity type> <context> The Just Spices Acquisition preliminarily resulted in $ 167 million of non-tax deductible goodwill relating principally to Just Spices’ social media presence. This goodwill was assigned to the Continental Europe reporting unit within our International Developed Markets segment. In 2022, certain insignificant measurement period adjustments were made to the initial allocation, and the final amount of goodwill was adjusted to $ 156 million. See Note 8, </context>
|
us-gaap:Goodwill
|
On March 11, 2024, we closed and finalized the sale of our infant nutrition business in Russia to a third party for total cash consideration of approximately $ 25 million (the “Russia Infant Transaction”). As a result of the Russia Infant Transaction, we recognized an insignificant pre-tax gain in other expense/(income) on our condensed consolidated statement of income in the first quarter of 2024.
|
text
|
25
|
monetaryItemType
|
text: <entity> 25 </entity> <entity type> monetaryItemType </entity type> <context> On March 11, 2024, we closed and finalized the sale of our infant nutrition business in Russia to a third party for total cash consideration of approximately $ 25 million (the “Russia Infant Transaction”). As a result of the Russia Infant Transaction, we recognized an insignificant pre-tax gain in other expense/(income) on our condensed consolidated statement of income in the first quarter of 2024. </context>
|
us-gaap:ProceedsFromDivestitureOfBusinesses
|
On February 5, 2024, we closed and finalized the sale of 100% of the equity interests in our Papua New Guinea subsidiary, Hugo Canning Company Limited, to a third party for total cash consideration of approximately $ 22 million, which is to be paid incrementally over two years following the transaction closing date (the “Papua New Guinea Transaction”). As a result of the Papua New Guinea Transaction, we recognized a pre-tax loss on sale of business of approximately $ 80 million in other expense/(income) on our condensed consolidated statement of income in the first quarter of 2024, of which approximately $ 41 million relates to the release of accumulated foreign currency losses.
|
text
|
22
|
monetaryItemType
|
text: <entity> 22 </entity> <entity type> monetaryItemType </entity type> <context> On February 5, 2024, we closed and finalized the sale of 100% of the equity interests in our Papua New Guinea subsidiary, Hugo Canning Company Limited, to a third party for total cash consideration of approximately $ 22 million, which is to be paid incrementally over two years following the transaction closing date (the “Papua New Guinea Transaction”). As a result of the Papua New Guinea Transaction, we recognized a pre-tax loss on sale of business of approximately $ 80 million in other expense/(income) on our condensed consolidated statement of income in the first quarter of 2024, of which approximately $ 41 million relates to the release of accumulated foreign currency losses. </context>
|
us-gaap:ProceedsFromDivestitureOfBusinesses
|
On February 5, 2024, we closed and finalized the sale of 100% of the equity interests in our Papua New Guinea subsidiary, Hugo Canning Company Limited, to a third party for total cash consideration of approximately $ 22 million, which is to be paid incrementally over two years following the transaction closing date (the “Papua New Guinea Transaction”). As a result of the Papua New Guinea Transaction, we recognized a pre-tax loss on sale of business of approximately $ 80 million in other expense/(income) on our condensed consolidated statement of income in the first quarter of 2024, of which approximately $ 41 million relates to the release of accumulated foreign currency losses.
|
text
|
80
|
monetaryItemType
|
text: <entity> 80 </entity> <entity type> monetaryItemType </entity type> <context> On February 5, 2024, we closed and finalized the sale of 100% of the equity interests in our Papua New Guinea subsidiary, Hugo Canning Company Limited, to a third party for total cash consideration of approximately $ 22 million, which is to be paid incrementally over two years following the transaction closing date (the “Papua New Guinea Transaction”). As a result of the Papua New Guinea Transaction, we recognized a pre-tax loss on sale of business of approximately $ 80 million in other expense/(income) on our condensed consolidated statement of income in the first quarter of 2024, of which approximately $ 41 million relates to the release of accumulated foreign currency losses. </context>
|
us-gaap:GainLossOnSaleOfBusiness
|
On February 5, 2024, we closed and finalized the sale of 100% of the equity interests in our Papua New Guinea subsidiary, Hugo Canning Company Limited, to a third party for total cash consideration of approximately $ 22 million, which is to be paid incrementally over two years following the transaction closing date (the “Papua New Guinea Transaction”). As a result of the Papua New Guinea Transaction, we recognized a pre-tax loss on sale of business of approximately $ 80 million in other expense/(income) on our condensed consolidated statement of income in the first quarter of 2024, of which approximately $ 41 million relates to the release of accumulated foreign currency losses.
|
text
|
41
|
monetaryItemType
|
text: <entity> 41 </entity> <entity type> monetaryItemType </entity type> <context> On February 5, 2024, we closed and finalized the sale of 100% of the equity interests in our Papua New Guinea subsidiary, Hugo Canning Company Limited, to a third party for total cash consideration of approximately $ 22 million, which is to be paid incrementally over two years following the transaction closing date (the “Papua New Guinea Transaction”). As a result of the Papua New Guinea Transaction, we recognized a pre-tax loss on sale of business of approximately $ 80 million in other expense/(income) on our condensed consolidated statement of income in the first quarter of 2024, of which approximately $ 41 million relates to the release of accumulated foreign currency losses. </context>
|
us-gaap:ForeignCurrencyTransactionGainLossRealized
|
The Powdered Cheese Transaction closed in the fourth quarter of 2022 for total cash consideration of approximately $ 108 million. As a result of the Powered Cheese Transaction closing, we recognized a pre-tax gain on sale of business of approximately $ 26 million in other expense/(income) on our consolidated statement of income.
|
text
|
108
|
monetaryItemType
|
text: <entity> 108 </entity> <entity type> monetaryItemType </entity type> <context> The Powdered Cheese Transaction closed in the fourth quarter of 2022 for total cash consideration of approximately $ 108 million. As a result of the Powered Cheese Transaction closing, we recognized a pre-tax gain on sale of business of approximately $ 26 million in other expense/(income) on our consolidated statement of income. </context>
|
us-gaap:ProceedsFromDivestitureOfBusinesses
|
The Powdered Cheese Transaction closed in the fourth quarter of 2022 for total cash consideration of approximately $ 108 million. As a result of the Powered Cheese Transaction closing, we recognized a pre-tax gain on sale of business of approximately $ 26 million in other expense/(income) on our consolidated statement of income.
|
text
|
26
|
monetaryItemType
|
text: <entity> 26 </entity> <entity type> monetaryItemType </entity type> <context> The Powdered Cheese Transaction closed in the fourth quarter of 2022 for total cash consideration of approximately $ 108 million. As a result of the Powered Cheese Transaction closing, we recognized a pre-tax gain on sale of business of approximately $ 26 million in other expense/(income) on our consolidated statement of income. </context>
|
us-gaap:GainLossOnSaleOfBusiness
|
We have restructuring programs globally, which are focused primarily on streamlining our organizational design. We eliminated approximately 270 positions in 2024. As of December 28, 2024, we expect to eliminate approximately 740 additional positions in 2025 across all zones. In 2024, restructuring activities resulted in net expenses of $ 20 million and included a net expense of $ 21 million of severance and employee benefit costs, a net benefit of $ 2 million of other exit costs, and a net expense of $ 1 million of asset-related cost. Restructuring activities resulted in expenses of $ 225 million in 2023 and $ 74 million in 2022.
|
text
|
270
|
integerItemType
|
text: <entity> 270 </entity> <entity type> integerItemType </entity type> <context> We have restructuring programs globally, which are focused primarily on streamlining our organizational design. We eliminated approximately 270 positions in 2024. As of December 28, 2024, we expect to eliminate approximately 740 additional positions in 2025 across all zones. In 2024, restructuring activities resulted in net expenses of $ 20 million and included a net expense of $ 21 million of severance and employee benefit costs, a net benefit of $ 2 million of other exit costs, and a net expense of $ 1 million of asset-related cost. Restructuring activities resulted in expenses of $ 225 million in 2023 and $ 74 million in 2022. </context>
|
us-gaap:RestructuringAndRelatedCostNumberOfPositionsEliminated
|
We have restructuring programs globally, which are focused primarily on streamlining our organizational design. We eliminated approximately 270 positions in 2024. As of December 28, 2024, we expect to eliminate approximately 740 additional positions in 2025 across all zones. In 2024, restructuring activities resulted in net expenses of $ 20 million and included a net expense of $ 21 million of severance and employee benefit costs, a net benefit of $ 2 million of other exit costs, and a net expense of $ 1 million of asset-related cost. Restructuring activities resulted in expenses of $ 225 million in 2023 and $ 74 million in 2022.
|
text
|
740
|
integerItemType
|
text: <entity> 740 </entity> <entity type> integerItemType </entity type> <context> We have restructuring programs globally, which are focused primarily on streamlining our organizational design. We eliminated approximately 270 positions in 2024. As of December 28, 2024, we expect to eliminate approximately 740 additional positions in 2025 across all zones. In 2024, restructuring activities resulted in net expenses of $ 20 million and included a net expense of $ 21 million of severance and employee benefit costs, a net benefit of $ 2 million of other exit costs, and a net expense of $ 1 million of asset-related cost. Restructuring activities resulted in expenses of $ 225 million in 2023 and $ 74 million in 2022. </context>
|
us-gaap:RestructuringAndRelatedCostExpectedNumberOfPositionsEliminated
|
We have restructuring programs globally, which are focused primarily on streamlining our organizational design. We eliminated approximately 270 positions in 2024. As of December 28, 2024, we expect to eliminate approximately 740 additional positions in 2025 across all zones. In 2024, restructuring activities resulted in net expenses of $ 20 million and included a net expense of $ 21 million of severance and employee benefit costs, a net benefit of $ 2 million of other exit costs, and a net expense of $ 1 million of asset-related cost. Restructuring activities resulted in expenses of $ 225 million in 2023 and $ 74 million in 2022.
|
text
|
20
|
monetaryItemType
|
text: <entity> 20 </entity> <entity type> monetaryItemType </entity type> <context> We have restructuring programs globally, which are focused primarily on streamlining our organizational design. We eliminated approximately 270 positions in 2024. As of December 28, 2024, we expect to eliminate approximately 740 additional positions in 2025 across all zones. In 2024, restructuring activities resulted in net expenses of $ 20 million and included a net expense of $ 21 million of severance and employee benefit costs, a net benefit of $ 2 million of other exit costs, and a net expense of $ 1 million of asset-related cost. Restructuring activities resulted in expenses of $ 225 million in 2023 and $ 74 million in 2022. </context>
|
us-gaap:RestructuringAndRelatedCostIncurredCost
|
We have restructuring programs globally, which are focused primarily on streamlining our organizational design. We eliminated approximately 270 positions in 2024. As of December 28, 2024, we expect to eliminate approximately 740 additional positions in 2025 across all zones. In 2024, restructuring activities resulted in net expenses of $ 20 million and included a net expense of $ 21 million of severance and employee benefit costs, a net benefit of $ 2 million of other exit costs, and a net expense of $ 1 million of asset-related cost. Restructuring activities resulted in expenses of $ 225 million in 2023 and $ 74 million in 2022.
|
text
|
21
|
monetaryItemType
|
text: <entity> 21 </entity> <entity type> monetaryItemType </entity type> <context> We have restructuring programs globally, which are focused primarily on streamlining our organizational design. We eliminated approximately 270 positions in 2024. As of December 28, 2024, we expect to eliminate approximately 740 additional positions in 2025 across all zones. In 2024, restructuring activities resulted in net expenses of $ 20 million and included a net expense of $ 21 million of severance and employee benefit costs, a net benefit of $ 2 million of other exit costs, and a net expense of $ 1 million of asset-related cost. Restructuring activities resulted in expenses of $ 225 million in 2023 and $ 74 million in 2022. </context>
|
us-gaap:RestructuringAndRelatedCostIncurredCost
|
We have restructuring programs globally, which are focused primarily on streamlining our organizational design. We eliminated approximately 270 positions in 2024. As of December 28, 2024, we expect to eliminate approximately 740 additional positions in 2025 across all zones. In 2024, restructuring activities resulted in net expenses of $ 20 million and included a net expense of $ 21 million of severance and employee benefit costs, a net benefit of $ 2 million of other exit costs, and a net expense of $ 1 million of asset-related cost. Restructuring activities resulted in expenses of $ 225 million in 2023 and $ 74 million in 2022.
|
text
|
2
|
monetaryItemType
|
text: <entity> 2 </entity> <entity type> monetaryItemType </entity type> <context> We have restructuring programs globally, which are focused primarily on streamlining our organizational design. We eliminated approximately 270 positions in 2024. As of December 28, 2024, we expect to eliminate approximately 740 additional positions in 2025 across all zones. In 2024, restructuring activities resulted in net expenses of $ 20 million and included a net expense of $ 21 million of severance and employee benefit costs, a net benefit of $ 2 million of other exit costs, and a net expense of $ 1 million of asset-related cost. Restructuring activities resulted in expenses of $ 225 million in 2023 and $ 74 million in 2022. </context>
|
us-gaap:RestructuringAndRelatedCostIncurredCost
|
We have restructuring programs globally, which are focused primarily on streamlining our organizational design. We eliminated approximately 270 positions in 2024. As of December 28, 2024, we expect to eliminate approximately 740 additional positions in 2025 across all zones. In 2024, restructuring activities resulted in net expenses of $ 20 million and included a net expense of $ 21 million of severance and employee benefit costs, a net benefit of $ 2 million of other exit costs, and a net expense of $ 1 million of asset-related cost. Restructuring activities resulted in expenses of $ 225 million in 2023 and $ 74 million in 2022.
|
text
|
1
|
monetaryItemType
|
text: <entity> 1 </entity> <entity type> monetaryItemType </entity type> <context> We have restructuring programs globally, which are focused primarily on streamlining our organizational design. We eliminated approximately 270 positions in 2024. As of December 28, 2024, we expect to eliminate approximately 740 additional positions in 2025 across all zones. In 2024, restructuring activities resulted in net expenses of $ 20 million and included a net expense of $ 21 million of severance and employee benefit costs, a net benefit of $ 2 million of other exit costs, and a net expense of $ 1 million of asset-related cost. Restructuring activities resulted in expenses of $ 225 million in 2023 and $ 74 million in 2022. </context>
|
us-gaap:RestructuringAndRelatedCostIncurredCost
|
We have restructuring programs globally, which are focused primarily on streamlining our organizational design. We eliminated approximately 270 positions in 2024. As of December 28, 2024, we expect to eliminate approximately 740 additional positions in 2025 across all zones. In 2024, restructuring activities resulted in net expenses of $ 20 million and included a net expense of $ 21 million of severance and employee benefit costs, a net benefit of $ 2 million of other exit costs, and a net expense of $ 1 million of asset-related cost. Restructuring activities resulted in expenses of $ 225 million in 2023 and $ 74 million in 2022.
|
text
|
225
|
monetaryItemType
|
text: <entity> 225 </entity> <entity type> monetaryItemType </entity type> <context> We have restructuring programs globally, which are focused primarily on streamlining our organizational design. We eliminated approximately 270 positions in 2024. As of December 28, 2024, we expect to eliminate approximately 740 additional positions in 2025 across all zones. In 2024, restructuring activities resulted in net expenses of $ 20 million and included a net expense of $ 21 million of severance and employee benefit costs, a net benefit of $ 2 million of other exit costs, and a net expense of $ 1 million of asset-related cost. Restructuring activities resulted in expenses of $ 225 million in 2023 and $ 74 million in 2022. </context>
|
us-gaap:RestructuringAndRelatedCostIncurredCost
|
We have restructuring programs globally, which are focused primarily on streamlining our organizational design. We eliminated approximately 270 positions in 2024. As of December 28, 2024, we expect to eliminate approximately 740 additional positions in 2025 across all zones. In 2024, restructuring activities resulted in net expenses of $ 20 million and included a net expense of $ 21 million of severance and employee benefit costs, a net benefit of $ 2 million of other exit costs, and a net expense of $ 1 million of asset-related cost. Restructuring activities resulted in expenses of $ 225 million in 2023 and $ 74 million in 2022.
|
text
|
74
|
monetaryItemType
|
text: <entity> 74 </entity> <entity type> monetaryItemType </entity type> <context> We have restructuring programs globally, which are focused primarily on streamlining our organizational design. We eliminated approximately 270 positions in 2024. As of December 28, 2024, we expect to eliminate approximately 740 additional positions in 2025 across all zones. In 2024, restructuring activities resulted in net expenses of $ 20 million and included a net expense of $ 21 million of severance and employee benefit costs, a net benefit of $ 2 million of other exit costs, and a net expense of $ 1 million of asset-related cost. Restructuring activities resulted in expenses of $ 225 million in 2023 and $ 74 million in 2022. </context>
|
us-gaap:RestructuringAndRelatedCostIncurredCost
|
At December 30, 2023, property, plant and equipment, net, excluded amounts classified as held for sale. Depreciation expense was $ 696 million in 2024, $ 710 million in 2023, and $ 672 million in 2022.
|
text
|
696
|
monetaryItemType
|
text: <entity> 696 </entity> <entity type> monetaryItemType </entity type> <context> At December 30, 2023, property, plant and equipment, net, excluded amounts classified as held for sale. Depreciation expense was $ 696 million in 2024, $ 710 million in 2023, and $ 672 million in 2022. </context>
|
us-gaap:Depreciation
|
At December 30, 2023, property, plant and equipment, net, excluded amounts classified as held for sale. Depreciation expense was $ 696 million in 2024, $ 710 million in 2023, and $ 672 million in 2022.
|
text
|
710
|
monetaryItemType
|
text: <entity> 710 </entity> <entity type> monetaryItemType </entity type> <context> At December 30, 2023, property, plant and equipment, net, excluded amounts classified as held for sale. Depreciation expense was $ 696 million in 2024, $ 710 million in 2023, and $ 672 million in 2022. </context>
|
us-gaap:Depreciation
|
At December 30, 2023, property, plant and equipment, net, excluded amounts classified as held for sale. Depreciation expense was $ 696 million in 2024, $ 710 million in 2023, and $ 672 million in 2022.
|
text
|
672
|
monetaryItemType
|
text: <entity> 672 </entity> <entity type> monetaryItemType </entity type> <context> At December 30, 2023, property, plant and equipment, net, excluded amounts classified as held for sale. Depreciation expense was $ 696 million in 2024, $ 710 million in 2023, and $ 672 million in 2022. </context>
|
us-gaap:Depreciation
|
On March 31, 2024, which was the first day of our second quarter of 2024, certain organizational changes occurred that impacted our reporting unit composition within our North America segment (the “Q2 North America reorganization”). Two of our North America reporting units — Taste, Meals, and Away From Home (“TMA”), and Fresh, Beverages, and Desserts (“FBD”) — were reorganized into the four reporting units: Taste Elevation, Ready Meals and Snacking (“TMS”), Hydration & Desserts (“HD”), Meat & Cheese (“MC”), and Away from Home & Kraft Heinz Ingredients (“AFH”). The Canada and North America Coffee (“CNAC”) and Other North America reporting units were not impacted by this reorganization.
|
text
|
Two
|
integerItemType
|
text: <entity> Two </entity> <entity type> integerItemType </entity type> <context> On March 31, 2024, which was the first day of our second quarter of 2024, certain organizational changes occurred that impacted our reporting unit composition within our North America segment (the “Q2 North America reorganization”). Two of our North America reporting units — Taste, Meals, and Away From Home (“TMA”), and Fresh, Beverages, and Desserts (“FBD”) — were reorganized into the four reporting units: Taste Elevation, Ready Meals and Snacking (“TMS”), Hydration & Desserts (“HD”), Meat & Cheese (“MC”), and Away from Home & Kraft Heinz Ingredients (“AFH”). The Canada and North America Coffee (“CNAC”) and Other North America reporting units were not impacted by this reorganization. </context>
|
us-gaap:NumberOfReportingUnits
|
As part of our Q2 North America pre-reorganization impairment test of the TMA and FBD reporting units, we utilized the discounted cash flow method under the income approach to estimate the fair values as of March 31, 2024, for these two reporting units and concluded that the fair value of these reporting units exceeded their carrying values and no impairment was recorded.
|
text
|
two
|
integerItemType
|
text: <entity> two </entity> <entity type> integerItemType </entity type> <context> As part of our Q2 North America pre-reorganization impairment test of the TMA and FBD reporting units, we utilized the discounted cash flow method under the income approach to estimate the fair values as of March 31, 2024, for these two reporting units and concluded that the fair value of these reporting units exceeded their carrying values and no impairment was recorded. </context>
|
us-gaap:NumberOfReportingUnits
|
We performed our Q2 North America post-reorganization impairment test as of March 31, 2024, and tested the new North America reporting units (TMS, HD, MC and AFH). We utilized the discounted cash flow method under the income approach to estimate the fair value of our reporting units. As a result of our Q2 North America post-reorganization impairment test, we recognized a non-cash impairment loss of approximately $ 854 million in SG&A in our North America segment in the second quarter of 2024. The $ 854 million impairment loss related to our MC reporting unit, which had a goodwill carrying amount of approximately $ 2.5 billion after impairment. The impairment of our MC reporting unit was driven by the disaggregation of the former FBD reporting unit, which previously held all the net assets for the HD and MC reporting units as well as the Snacking category of TMS. The other three reporting units for which no impairment charge was required were TMS, which had a goodwill carrying amount of approximately $ 15.9 billion; HD, which had a goodwill carrying amount of approximately $ 4.3 billion; and AFH, which had a goodwill carrying amount of approximately $ 2.8 billion.
|
text
|
2.5
|
monetaryItemType
|
text: <entity> 2.5 </entity> <entity type> monetaryItemType </entity type> <context> We performed our Q2 North America post-reorganization impairment test as of March 31, 2024, and tested the new North America reporting units (TMS, HD, MC and AFH). We utilized the discounted cash flow method under the income approach to estimate the fair value of our reporting units. As a result of our Q2 North America post-reorganization impairment test, we recognized a non-cash impairment loss of approximately $ 854 million in SG&A in our North America segment in the second quarter of 2024. The $ 854 million impairment loss related to our MC reporting unit, which had a goodwill carrying amount of approximately $ 2.5 billion after impairment. The impairment of our MC reporting unit was driven by the disaggregation of the former FBD reporting unit, which previously held all the net assets for the HD and MC reporting units as well as the Snacking category of TMS. The other three reporting units for which no impairment charge was required were TMS, which had a goodwill carrying amount of approximately $ 15.9 billion; HD, which had a goodwill carrying amount of approximately $ 4.3 billion; and AFH, which had a goodwill carrying amount of approximately $ 2.8 billion. </context>
|
us-gaap:Goodwill
|
We performed our Q2 North America post-reorganization impairment test as of March 31, 2024, and tested the new North America reporting units (TMS, HD, MC and AFH). We utilized the discounted cash flow method under the income approach to estimate the fair value of our reporting units. As a result of our Q2 North America post-reorganization impairment test, we recognized a non-cash impairment loss of approximately $ 854 million in SG&A in our North America segment in the second quarter of 2024. The $ 854 million impairment loss related to our MC reporting unit, which had a goodwill carrying amount of approximately $ 2.5 billion after impairment. The impairment of our MC reporting unit was driven by the disaggregation of the former FBD reporting unit, which previously held all the net assets for the HD and MC reporting units as well as the Snacking category of TMS. The other three reporting units for which no impairment charge was required were TMS, which had a goodwill carrying amount of approximately $ 15.9 billion; HD, which had a goodwill carrying amount of approximately $ 4.3 billion; and AFH, which had a goodwill carrying amount of approximately $ 2.8 billion.
|
text
|
15.9
|
monetaryItemType
|
text: <entity> 15.9 </entity> <entity type> monetaryItemType </entity type> <context> We performed our Q2 North America post-reorganization impairment test as of March 31, 2024, and tested the new North America reporting units (TMS, HD, MC and AFH). We utilized the discounted cash flow method under the income approach to estimate the fair value of our reporting units. As a result of our Q2 North America post-reorganization impairment test, we recognized a non-cash impairment loss of approximately $ 854 million in SG&A in our North America segment in the second quarter of 2024. The $ 854 million impairment loss related to our MC reporting unit, which had a goodwill carrying amount of approximately $ 2.5 billion after impairment. The impairment of our MC reporting unit was driven by the disaggregation of the former FBD reporting unit, which previously held all the net assets for the HD and MC reporting units as well as the Snacking category of TMS. The other three reporting units for which no impairment charge was required were TMS, which had a goodwill carrying amount of approximately $ 15.9 billion; HD, which had a goodwill carrying amount of approximately $ 4.3 billion; and AFH, which had a goodwill carrying amount of approximately $ 2.8 billion. </context>
|
us-gaap:Goodwill
|
We performed our Q2 North America post-reorganization impairment test as of March 31, 2024, and tested the new North America reporting units (TMS, HD, MC and AFH). We utilized the discounted cash flow method under the income approach to estimate the fair value of our reporting units. As a result of our Q2 North America post-reorganization impairment test, we recognized a non-cash impairment loss of approximately $ 854 million in SG&A in our North America segment in the second quarter of 2024. The $ 854 million impairment loss related to our MC reporting unit, which had a goodwill carrying amount of approximately $ 2.5 billion after impairment. The impairment of our MC reporting unit was driven by the disaggregation of the former FBD reporting unit, which previously held all the net assets for the HD and MC reporting units as well as the Snacking category of TMS. The other three reporting units for which no impairment charge was required were TMS, which had a goodwill carrying amount of approximately $ 15.9 billion; HD, which had a goodwill carrying amount of approximately $ 4.3 billion; and AFH, which had a goodwill carrying amount of approximately $ 2.8 billion.
|
text
|
4.3
|
monetaryItemType
|
text: <entity> 4.3 </entity> <entity type> monetaryItemType </entity type> <context> We performed our Q2 North America post-reorganization impairment test as of March 31, 2024, and tested the new North America reporting units (TMS, HD, MC and AFH). We utilized the discounted cash flow method under the income approach to estimate the fair value of our reporting units. As a result of our Q2 North America post-reorganization impairment test, we recognized a non-cash impairment loss of approximately $ 854 million in SG&A in our North America segment in the second quarter of 2024. The $ 854 million impairment loss related to our MC reporting unit, which had a goodwill carrying amount of approximately $ 2.5 billion after impairment. The impairment of our MC reporting unit was driven by the disaggregation of the former FBD reporting unit, which previously held all the net assets for the HD and MC reporting units as well as the Snacking category of TMS. The other three reporting units for which no impairment charge was required were TMS, which had a goodwill carrying amount of approximately $ 15.9 billion; HD, which had a goodwill carrying amount of approximately $ 4.3 billion; and AFH, which had a goodwill carrying amount of approximately $ 2.8 billion. </context>
|
us-gaap:Goodwill
|
We performed our Q2 North America post-reorganization impairment test as of March 31, 2024, and tested the new North America reporting units (TMS, HD, MC and AFH). We utilized the discounted cash flow method under the income approach to estimate the fair value of our reporting units. As a result of our Q2 North America post-reorganization impairment test, we recognized a non-cash impairment loss of approximately $ 854 million in SG&A in our North America segment in the second quarter of 2024. The $ 854 million impairment loss related to our MC reporting unit, which had a goodwill carrying amount of approximately $ 2.5 billion after impairment. The impairment of our MC reporting unit was driven by the disaggregation of the former FBD reporting unit, which previously held all the net assets for the HD and MC reporting units as well as the Snacking category of TMS. The other three reporting units for which no impairment charge was required were TMS, which had a goodwill carrying amount of approximately $ 15.9 billion; HD, which had a goodwill carrying amount of approximately $ 4.3 billion; and AFH, which had a goodwill carrying amount of approximately $ 2.8 billion.
|
text
|
2.8
|
monetaryItemType
|
text: <entity> 2.8 </entity> <entity type> monetaryItemType </entity type> <context> We performed our Q2 North America post-reorganization impairment test as of March 31, 2024, and tested the new North America reporting units (TMS, HD, MC and AFH). We utilized the discounted cash flow method under the income approach to estimate the fair value of our reporting units. As a result of our Q2 North America post-reorganization impairment test, we recognized a non-cash impairment loss of approximately $ 854 million in SG&A in our North America segment in the second quarter of 2024. The $ 854 million impairment loss related to our MC reporting unit, which had a goodwill carrying amount of approximately $ 2.5 billion after impairment. The impairment of our MC reporting unit was driven by the disaggregation of the former FBD reporting unit, which previously held all the net assets for the HD and MC reporting units as well as the Snacking category of TMS. The other three reporting units for which no impairment charge was required were TMS, which had a goodwill carrying amount of approximately $ 15.9 billion; HD, which had a goodwill carrying amount of approximately $ 4.3 billion; and AFH, which had a goodwill carrying amount of approximately $ 2.8 billion. </context>
|
us-gaap:Goodwill
|
We performed our 2024 annual impairment test as of June 30, 2024, which was the first day of our third quarter of 2024. We utilized the discounted cash flow method under the income approach to estimate the fair value of our reporting units. As a result of our 2024 annual impairment test, we recognized non-cash goodwill impairment losses in SG&A of approximately $ 495 million related to our Continental Europe reporting unit within our International Developed Markets segment, $ 184 million related to our LATAM reporting unit within Emerging Markets, and $ 105 million related to our AFH reporting unit within our North America segment. The impairment of our Continental Europe reporting unit was primarily driven by a reduction of future year profitability assumptions from prior estimates in non-core categories and the
|
text
|
495
|
monetaryItemType
|
text: <entity> 495 </entity> <entity type> monetaryItemType </entity type> <context> We performed our 2024 annual impairment test as of June 30, 2024, which was the first day of our third quarter of 2024. We utilized the discounted cash flow method under the income approach to estimate the fair value of our reporting units. As a result of our 2024 annual impairment test, we recognized non-cash goodwill impairment losses in SG&A of approximately $ 495 million related to our Continental Europe reporting unit within our International Developed Markets segment, $ 184 million related to our LATAM reporting unit within Emerging Markets, and $ 105 million related to our AFH reporting unit within our North America segment. The impairment of our Continental Europe reporting unit was primarily driven by a reduction of future year profitability assumptions from prior estimates in non-core categories and the </context>
|
us-gaap:GoodwillImpairmentLoss
|
We performed our 2024 annual impairment test as of June 30, 2024, which was the first day of our third quarter of 2024. We utilized the discounted cash flow method under the income approach to estimate the fair value of our reporting units. As a result of our 2024 annual impairment test, we recognized non-cash goodwill impairment losses in SG&A of approximately $ 495 million related to our Continental Europe reporting unit within our International Developed Markets segment, $ 184 million related to our LATAM reporting unit within Emerging Markets, and $ 105 million related to our AFH reporting unit within our North America segment. The impairment of our Continental Europe reporting unit was primarily driven by a reduction of future year profitability assumptions from prior estimates in non-core categories and the
|
text
|
184
|
monetaryItemType
|
text: <entity> 184 </entity> <entity type> monetaryItemType </entity type> <context> We performed our 2024 annual impairment test as of June 30, 2024, which was the first day of our third quarter of 2024. We utilized the discounted cash flow method under the income approach to estimate the fair value of our reporting units. As a result of our 2024 annual impairment test, we recognized non-cash goodwill impairment losses in SG&A of approximately $ 495 million related to our Continental Europe reporting unit within our International Developed Markets segment, $ 184 million related to our LATAM reporting unit within Emerging Markets, and $ 105 million related to our AFH reporting unit within our North America segment. The impairment of our Continental Europe reporting unit was primarily driven by a reduction of future year profitability assumptions from prior estimates in non-core categories and the </context>
|
us-gaap:GoodwillImpairmentLoss
|
We performed our 2024 annual impairment test as of June 30, 2024, which was the first day of our third quarter of 2024. We utilized the discounted cash flow method under the income approach to estimate the fair value of our reporting units. As a result of our 2024 annual impairment test, we recognized non-cash goodwill impairment losses in SG&A of approximately $ 495 million related to our Continental Europe reporting unit within our International Developed Markets segment, $ 184 million related to our LATAM reporting unit within Emerging Markets, and $ 105 million related to our AFH reporting unit within our North America segment. The impairment of our Continental Europe reporting unit was primarily driven by a reduction of future year profitability assumptions from prior estimates in non-core categories and the
|
text
|
105
|
monetaryItemType
|
text: <entity> 105 </entity> <entity type> monetaryItemType </entity type> <context> We performed our 2024 annual impairment test as of June 30, 2024, which was the first day of our third quarter of 2024. We utilized the discounted cash flow method under the income approach to estimate the fair value of our reporting units. As a result of our 2024 annual impairment test, we recognized non-cash goodwill impairment losses in SG&A of approximately $ 495 million related to our Continental Europe reporting unit within our International Developed Markets segment, $ 184 million related to our LATAM reporting unit within Emerging Markets, and $ 105 million related to our AFH reporting unit within our North America segment. The impairment of our Continental Europe reporting unit was primarily driven by a reduction of future year profitability assumptions from prior estimates in non-core categories and the </context>
|
us-gaap:GoodwillImpairmentLoss
|
business, as well as higher intercompany royalty expenses resulting from a change in our product mix. The impairment of our LATAM reporting unit was primarily driven by a reduction of future year profitability assumptions from prior estimates and negative macroeconomic factors, including weakening of the foreign currency exchange rate of the Brazilian real relative to the U.S. dollar. After these impairments, the goodwill carrying amount was approximately $ 2.7 billion in our AFH reporting unit, approximately $ 485 million in our Continental Europe reporting unit, and there is no goodwill carrying value remaining in our LATAM reporting unit.
|
text
|
2.7
|
monetaryItemType
|
text: <entity> 2.7 </entity> <entity type> monetaryItemType </entity type> <context> business, as well as higher intercompany royalty expenses resulting from a change in our product mix. The impairment of our LATAM reporting unit was primarily driven by a reduction of future year profitability assumptions from prior estimates and negative macroeconomic factors, including weakening of the foreign currency exchange rate of the Brazilian real relative to the U.S. dollar. After these impairments, the goodwill carrying amount was approximately $ 2.7 billion in our AFH reporting unit, approximately $ 485 million in our Continental Europe reporting unit, and there is no goodwill carrying value remaining in our LATAM reporting unit. </context>
|
us-gaap:Goodwill
|
business, as well as higher intercompany royalty expenses resulting from a change in our product mix. The impairment of our LATAM reporting unit was primarily driven by a reduction of future year profitability assumptions from prior estimates and negative macroeconomic factors, including weakening of the foreign currency exchange rate of the Brazilian real relative to the U.S. dollar. After these impairments, the goodwill carrying amount was approximately $ 2.7 billion in our AFH reporting unit, approximately $ 485 million in our Continental Europe reporting unit, and there is no goodwill carrying value remaining in our LATAM reporting unit.
|
text
|
485
|
monetaryItemType
|
text: <entity> 485 </entity> <entity type> monetaryItemType </entity type> <context> business, as well as higher intercompany royalty expenses resulting from a change in our product mix. The impairment of our LATAM reporting unit was primarily driven by a reduction of future year profitability assumptions from prior estimates and negative macroeconomic factors, including weakening of the foreign currency exchange rate of the Brazilian real relative to the U.S. dollar. After these impairments, the goodwill carrying amount was approximately $ 2.7 billion in our AFH reporting unit, approximately $ 485 million in our Continental Europe reporting unit, and there is no goodwill carrying value remaining in our LATAM reporting unit. </context>
|
us-gaap:Goodwill
|
As of our 2024 annual impairment test, our reporting units with 20 % or less fair value over carrying amount had an aggregate goodwill carrying amount of $ 24.1 billion and included TMS, AFH, MC, Northern Europe, CNAC, and Continental Europe. Our HD and Asia reporting units had 20 - 50 % fair value over carrying amount with an aggregate goodwill carrying amount of $ 4.6 billion as of our 2024 annual impairment test date.
|
text
|
20
|
percentItemType
|
text: <entity> 20 </entity> <entity type> percentItemType </entity type> <context> As of our 2024 annual impairment test, our reporting units with 20 % or less fair value over carrying amount had an aggregate goodwill carrying amount of $ 24.1 billion and included TMS, AFH, MC, Northern Europe, CNAC, and Continental Europe. Our HD and Asia reporting units had 20 - 50 % fair value over carrying amount with an aggregate goodwill carrying amount of $ 4.6 billion as of our 2024 annual impairment test date. </context>
|
us-gaap:ReportingUnitPercentageOfFairValueInExcessOfCarryingAmount
|
As of our 2024 annual impairment test, our reporting units with 20 % or less fair value over carrying amount had an aggregate goodwill carrying amount of $ 24.1 billion and included TMS, AFH, MC, Northern Europe, CNAC, and Continental Europe. Our HD and Asia reporting units had 20 - 50 % fair value over carrying amount with an aggregate goodwill carrying amount of $ 4.6 billion as of our 2024 annual impairment test date.
|
text
|
24.1
|
monetaryItemType
|
text: <entity> 24.1 </entity> <entity type> monetaryItemType </entity type> <context> As of our 2024 annual impairment test, our reporting units with 20 % or less fair value over carrying amount had an aggregate goodwill carrying amount of $ 24.1 billion and included TMS, AFH, MC, Northern Europe, CNAC, and Continental Europe. Our HD and Asia reporting units had 20 - 50 % fair value over carrying amount with an aggregate goodwill carrying amount of $ 4.6 billion as of our 2024 annual impairment test date. </context>
|
us-gaap:Goodwill
|
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.